UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )

Filed by the Registrant[X]
Filed by a Party other than the Registrant[   ]

Check the appropriate box:
 

[  ]Preliminary Proxy Statement
[  ]Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[X]Definitive Proxy Statement
[  ]Definitive Additional Materials
[  ]Soliciting Material Pursuant to Section 240.14a-12


KINGSTONE COMPANIES, INC.
(Name of Registrant as Specified in its Charter)


(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)


Payment of Filing Fee (Check the appropriate box)all boxes that apply):
  
[X]
No fee required
required.
[   ]Fee paid previously with preliminary materials.
Fee computed on table belowin exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
1)Title of each class of securities to which transaction applies:
2)Aggregate number of securities to which transaction applies:

3)Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
4)Proposed maximum aggregate value of transaction:
5)Total fee paid:


[   ]
Fee paid previously with preliminary materials.
[   ]Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)  and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
1)Amount previously paid:
2)Form, Schedule or Registration Statement No.:
3)Filing Party:
4)Date Filed:

KINGSTONE COMPANIES, INC.
15 Joys Lane
Kingston, New York 12401

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON AUGUST 10, 20219, 2023

To the Stockholders of Kingstone Companies, Inc.:
 
NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Kingstone Companies, Inc., a Delaware corporation (the “Company” or “we”), will be held on August 10, 20219, 2023, at 15 Joys Lane, Kingston, New York 12401, at 9:00 a.m., for the following purposes:

1.To elect six directors for the coming year.

2.To approve an amendment to the Company’s Amended and Restated 2014 Equity Participation Plan (the “2014 Plan”) to increase the number of shares of common stock authorized to be issued pursuant to the 2014 Plan from 1,400,000 to 1,900,000.

3.To ratify the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.

3.To approve the Kingstone Companies, Inc. Employee Stock Purchase Plan.2023.

4.To hold a non-binding advisory vote to approve the Company’s executive compensation.

5.To transact such other business as may properly come before the meeting.

Only stockholders of record at the close of business on June 17, 202115, 2023, are entitled to notice of and to vote at the meeting or at any adjournment thereof.

Important notice regarding the availability of Proxy Materials: We are sending a Notice of Internet Availability of Proxy Materials (the “Notice”) to our stockholders of record and beneficial owners, unless they have directed us to provide the materials in a different manner. The Notice provides instructions on how to access and review all of the important information contained in this proxy statement, as well as how to submit a proxy by telephone or over the Internet. If you receive the Notice and would still like to receive a printed copy of our proxy materials, instructions for requesting these materials are included in the Notice. The Company plans to mail the Notice to stockholders by June 30, 2021.29, 2023. The proxy statement and the Company’s Annual Report on Form 10-K for the year ended December 31, 20202022, are available electronically to the Company’s stockholders of record as of the close of business on June 17, 202115, 2023, at www.proxyvote.com.


Floyd R. Tupper
Secretary

Kingston, New York
June 30, 202129, 2023


WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE SUBMIT YOUR PROXY OR VOTING INSTRUCTIONS AS SOON AS POSSIBLE. FOR SPECIFIC INSTRUCTIONS ON HOW TO VOTE YOUR SHARES, PLEASE REFER TO THE INSTRUCTIONS IN THE NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS YOU RECEIVED IN THE MAIL OR, IF YOU REQUESTED TO RECEIVE PRINTED PROXY MATERIALS, YOUR ENCLOSED PROXY CARD. ANY STOCKHOLDER MAY REVOKE A SUBMITTED PROXY AT ANY TIME BEFORE THE MEETING BY WRITTEN NOTICE TO SUCH EFFECT, BY SUBMITTING A SUBSEQUENTLY DATED PROXY OR BY ATTENDING THE MEETING AND VOTING IN PERSON. THOSE VOTING BY INTERNET OR BY TELEPHONE MAY ALSO REVOKE THEIR PROXY BY VOTING IN PERSON AT THE MEETING OR BY VOTING AND SUBMITTING THEIR PROXY AT A LATER TIME BY INTERNET OR BY TELEPHONE.

KINGSTONE COMPANIES, INC.
15 Joys Lane
Kingston, New York 12401
____________________________

PROXY STATEMENT
____________________________

SOLICITING, VOTING AND REVOCABILITY OF PROXY

This proxy statement is being made available to all stockholders of record at the close of business on June 17, 202115, 2023, in connection with the solicitation by the Board of Directors of proxies to be voted at the Annual Meeting of Stockholders to be held on August 10, 20219, 2023, at 9:00 a.m., local time, or any adjournment thereof. Proxy materials for the Annual Meeting of Stockholders were made available to stockholders on or about June 30, 2021.29, 2023.

All shares represented by proxies duly executed and received will be voted on the matters presented at the meeting in accordance with the instructions specified in such proxies. Proxies so received without specified instructions will be voted as follows:

(i)
FOR the nominees named in the proxy to our Board of Directors;

(ii)
FOR the proposal to approve an amendment to our Amended and Restated 2014 Equity Participation Plan (the “2014 Plan”) to increase the number of shares of common stock authorized to be issued pursuant to the 2014 Plan from 1,400,000 to 1,900,000;

(iii)
FOR the ratification of the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;

(iii)
FOR2023; the approval of the Kingstone Companies, Inc. Employee Stock Purchase Plan;

(iv)
FORthe approval of the compensation of our named executive officers.

If you are a beneficial owner of shares held in street name and you do not provide specific voting instructions to the organization that holds your shares, the organization will be prohibited under the current rules of the New York Stock Exchange from voting your shares on “non-routine” matters. This is commonly referred to as a “broker non-vote.” The election of directors, the proposalapproval of the amendment to approve the Kingstone Companies, Inc. 2021 Employee Stock Purchase2014 Plan and the advisory vote on the approval of executive compensation are considered “non-routine” matters and therefore may not be voted on by your bank or broker absent specific instructions from you. The ratification of the selection of our independent registered public accounting firm is a routine matter. Please instruct your bank or broker so your vote can be counted.

Our Board of Directors does not know of any other matters that may be brought before the meeting nor does it foresee or have reason to believe that the proxy holder will have to vote for substitute or alternate nominees to the Board of Directors. In the event that any other matter should come before the meeting or any nominee is not available for election, the person named in the enclosed proxy will have discretionary authority to vote all proxies not marked to the contrary with respect to such matters in accordance with his best judgment.


The total number of shares of common stock outstanding and entitled to vote as of the close of business on June 17, 202115, 2023 was 10,689,138.10,755,964. Our common stock is the only class of securities entitled to vote on matters presented to our stockholders, each share being entitled to one vote. A majority of the shares of common stock outstanding and entitled to vote as of the close of business on June 17, 2021,15, 2023, or 5,344,5705,377,983 shares of common stock, must be present at the meeting in person or by proxy in order to constitute a quorum for the transaction of business.

Our Restated Certificate of Incorporation provides for cumulative voting of shares for the election of directors. This means that each stockholder has the right to cumulate his votes and give to one or more nominees as many votes as equals the number of directors to be elected (six) multiplied by the number of shares he is entitled to vote. A stockholder may therefore cast his votes for one nominee or distribute them among two or more of the nominees; however, in order to cumulate votes, a stockholder must request a proxy card (as Internet and telephone voting will not be available for such purposes). Only stockholders of record as of the close of business on June 17, 202115, 2023, will be entitled to vote. With regard to the election of directors, votes may be cast in favor or withheld. The directors shall be elected by a plurality of the votes cast in favor. Accordingly, based upon there being six nominees, each person who receives one or more votes will be elected as a director. Votes withheld in connection with the election of one or more of the nominees for director will not be counted as votes cast for such individuals and may be voted for the other nominees.

Stockholders may expressly abstain from voting on Proposals 2, 3 and 4 by so indicating on the proxy.  Abstentions are counted as present in the tabulation of votes on Proposals 2, 3 and 4.  Since each of Proposals 2, 3 and 4 requires the affirmative approval of a majority of the shares of common stock present in person or represented by proxy at the meeting and entitled to vote (assuming a quorum is present at the meeting), abstentions will have the effect of a negative vote while broker non-votes will have no effect.

Any person giving a proxy in the form accompanying this proxy statement has the power to revoke it at any time before its exercise. The proxy may be revoked by filing with us written notice of revocation or a fully executed proxy bearing a later date. The proxy may also be revoked by affirmatively electing to vote in person while in attendance at the meeting. However, a stockholder who attends the meeting need not revoke a proxy given and vote in person unless the stockholder wishes to do so. Written revocations or amended proxies should be sent to us at 15 Joys Lane, Kingston, New York 12401, Attention: Corporate Secretary. Those voting by Internet or by telephone may also revoke their proxy by voting in person at the meeting or by voting and submitting their proxy at a later time by Internet or by telephone.

The proxy is being solicited by our Board of Directors. We will bear the cost of the solicitation of proxies, including the charges and expenses of brokerage firms and other custodians, nominees and fiduciaries for forwarding proxy materials to beneficial owners of our shares. Solicitations will be made primarily by Internet availability of proxy materials and by mail, but certain of our directors, officers or employees may solicit proxies in person or by telephone, telecopier or email without special compensation.

5

A list of stockholders entitled to vote at the meeting will be available for examination by any stockholder for any purpose germane to the meeting, during ordinary business hours, for ten days prior to the meeting, at our offices located at 15 Joys Lane, Kingston, New York 12401, and also during the whole time of the meeting for inspection by any stockholder who is present. To contact us, stockholders should call (845) 802-7900.

EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth certain information concerning the compensation for the fiscal years ended December 31, 20202022 and 20192021, for certain executive officers, including our Chief Executive Officer (“CEO”) (collectively, the “Named Executive Officers” or “NEOs”):

 
Name and Principal Position
Year
 
Salary
 
Bonus
Stock Awards(5)Option Awards(5)
Non-Equity
Incentive Plan
Compensation(8)
 
All Other
Compensation
 
 
Total
Barry B. Goldstein (1)
2020
$500,000
$-
$1,386,500(6)
$-
$-
$32,609 (9)
$1,919,109
   Chief Executive Officer;
   Executive Chairman of the
   Board
2019
$636,500
$-
$-
$-
$-
$37,520 (10)
$674,020
         
Meryl S. Golden (2)
2020
$500,000
$73,646
$-
$-
$-
$23,400 (11)
$597,046
   Chief Operating Officer
2019
$134,247
$ -
$-
$95,450(7) 
$-
$6,277 (12)
$235,974
 
 
    
    
    
    
    
    
    
Victor J. Brodsky (3)
2020
$279,975
$-
$-
$43,451
$-
$269,269 (13)
$592,785
   Chief Financial Officer
2019
$369,666 
$- 
$150,000 
$- 
$34,508
$22,042 (14)
$576,217
         
Benjamin Walden (4)
2020
$258,490
$-
$-
$31,560
$-
$108,847 (15)
$398,897
    Executive Vice President and
    Chief Actuary, Kingstone
    Insurance Company
2019
$339,025
$-
$135,000
$-
$31,601
$11,200 (16)
$516,825
 
Name and Principal Position
Year
 
Salary
 
Bonus
Stock
Awards(1)
Option
Awards(1)
Non-Equity
Incentive Plan
Compensation
 
All Other
Compensation
 
 
Total
Barry B. Goldstein2022$500,000$    -$136,500(2)$      -$          -$24,200(7)$660,700
   Chief Executive Officer;
   Executive Chairman of
   the Board
 
2021
 
$500,000
 
$    -
 
$1,386,500(3)
 
$      -
 
$          -
 
$34,935(8)
 
$1,921,435
         
Meryl S. Golden2022$500,000$    -$150,000(4)$      -$          -$24,200(9)$674,200
   Chief Operating Officer;
   President, Kingstone
   Insurance Company
2021
 
$500,000
 
$    -
 
$211,020(5)
 
$      -
 
$          -
 
$23,600(10)
 
$734,620
 
         
Sarah (Minlei) Chen2022$306,620$   -$   -$      -$          -$6,994(11)$313,614
   Chief Actuary,
    Senior Vice President,
    Kingstone Insurance
    Company
2021
 
$267,515
 
$40,000
 
$36,520(6)
 
$      -
 
$          -
 
$6,588(11)
 
$350,623
 
_________
 (1) Mr. Goldstein has served as our Chief Executive Officer since July 19, 2019 and Executive Chairman of the Board since January 1, 2019.  He previously served as Chief Executive Officer from March 2001 through December 31, 2018.

(2) Ms. Golden has served as our Chief Operating Officer since September 2019.

(3) Mr. Brodsky served as our Chief Financial officer until September 30, 2020.

(4) Mr. Walden served as Executive Vice President and Chief Actuary of our wholly-owned subsidiary, Kingstone Insurance Company (“KICO”), until September 30, 2020.

(5) 
(1)Amounts reflect the aggregate grant date fair value of grants made in each respective fiscal year computed in accordance with stock-based accounting rules (FASB ASC Topic 718-Stock Compensation), excluding the effect of estimated forfeitures. Assumptions used in the calculations of these amounts are included in Note 12 to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, available electronically to our stockholders.
(2)In January 2022, Mr. Goldstein was granted 27,300 shares of restricted common stock under the 2014 Plan. Such grant vests to the extent of 13,650 shares as of December 29, 2023, and 13,650 shares as of December 30, 2024. See “Termination of Employment and Change-in-Control Arrangements – Barry B. Goldstein” below for a discussion of certain provisions relating to the restricted stock granted to Mr. Goldstein.
(3)In January 2021, Mr. Goldstein was granted an aggregate of 251,769 shares of restricted common stock under the 2014 Plan. Such grant vested to the extent of 125,885 shares as of the first anniversary of the date of grant and vests to the extent of 62,942 shares as of December 29, 2023, and 62,942 shares as of December 30, 2024. See “Termination of Employment and Change-in-Control Arrangements – Barry B. Goldstein” below for a discussion of certain provisions relating to the restricted stock granted to Mr. Goldstein.

6

(4)In January 2022, Ms. Golden was granted 30,000 shares of restricted common stock under the 2014 Plan. Such grant vested to the extent of 10,000 shares as of the first anniversary of the date of grant and vests to the extent of 10,000 shares as of each of the second and third anniversaries of the date of grant. See “Termination of Employment and Change-in-Control Arrangements – Meryl Golden” below for a discussion of certain provisions relating to the restricted stock granted to Ms. Golden.
(5)In January 2021, Ms. Golden was granted 30,000 shares of restricted common stock under the 2014 Plan. Such grant vested to the extent of 10,000 shares as of each of the first and second anniversaries of the date of grant and vests to the extent of 10,000 shares as of the third anniversary of the date of grant. In addition, in December 2021, Ms. Golden was granted 2,400 shares of restricted stock under the 2014 Plan. Such grant vested to the extent of 800 shares as of the first anniversary of the date of grant and vests to the extent of 800 shares as of each of the second and third anniversaries of the date of grant. See “Termination of Employment and Change-in-Control Arrangements – Meryl Golden” below for a discussion of certain provisions relating to the restricted stock granted to Ms. Golden.
(6)In January 2021, Ms. Chen was granted 3,572 shares of restricted common stock under the 2014 Plan. Such grant vested to the extent of 1,191 shares as of each of the first and second anniversaries of the date of grant and vests to the extent of 1,190 shares as of the third anniversary of the date of grant. In addition, in December 2021, Ms. Chen was granted 2,400 shares of restricted stock under the 2014 Plan. Such grant vested to the extent of 800 shares as of the first anniversary of the date of grant and vests to the extent of 800 shares as of each of the second and third anniversaries of the date of grant. See “Termination of Employment and Change-in-Control Arrangements – Sarah (Minlei) Chen” below for a discussion of certain provisions relating to the restricted stock granted to Ms. Chen.
(7)Represents employer matching contributions under our defined contribution plan of $12,200 and a car allowance of $12,000.
(8)Represents employer matching contributions under our deferred compensation plan (which was terminated in December 2022) of $11,335, employer matching contributions under our defined contribution plan of $11,600 and a car allowance of $12,000.
(9)Represents employer matching contributions under our defined contribution plan of $12,200 and a car allowance of $12,000.
(10)Represents employer matching contributions under our defined contribution plan of $11,600 and a car allowance of $12,000.
(11)Represents employer matching contributions under our defined contribution plan.

Pay Versus Performance (PvP) Table

The table below is provided in accordance with stock-based accounting rules (FASB ASC Topic 718-Stock Compensation), excludingItem 402(v) of Regulation S-K. We are providing the effect of estimated forfeitures. Assumptions used infollowing information about the calculations of these amounts are included in Note 12relationship between executive compensation actually paid to our Consolidated Financial Statements included in the Annual Report available electronically toCEO and our stockholders.

(6) In January 2020, Mr. Goldstein was granted an aggregate of 174,622 shares of restricted common stock under our 2014 Equity Participation Plan (the “2014 Plan”).  Such grant vested to the extent of 58,208 shares asother Named Executive Officers and certain financial performance of the first anniversary of the date of grant and vests to the extent of 58,207 shares as ofCompany for each of the second anniversary of the date of grant andfiscal years ended December 31, 2022.  See “Termination of Employment2022 and Change-in-Control Arrangements – Barry B. Goldstein” below for a discussion of certain provisions relating to the restricted stock granted to Mr. Goldstein.2021:
7

Fiscal
Year
Summary
Compensation
Table Total
for CEO(1)
Compensation
Actually Paid
to CEO(2)
Average Summary
Compensation
Table for
Non-CEO NEOs(3)
Average
Compensation
Actually Paid to
Non-CEO NEOs(4)
Value of Initial
Fixed $100 Investment
Based On
Total
Stockholder
Return(5)
Net Loss(6)
2022$660,700$(64,300)$493,907$387,280$111.66$(22,524,794)
       
2021$1,921,435$1,601,697$542,622$511,682$67.48$(7,378,301)
_________

(1)The dollar amounts reported are the amounts of total compensation reported in the “Total” column of our Summary Compensation Table for Mr. Goldstein.
(2)The dollar amounts reported represent the amount of “compensation actually paid,” as computed in accordance with SEC rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with SEC rules, the following adjustments were made to total compensation to determine the compensation actually paid:
(7) In September 2019, Ms. Golden was granted a five-year option under the 2014 Plan for the purchase of 50,000 shares of common stock at an exercise price of $8.72 per share.  Such option became exercisable to the extent of 12,500 shares as of each of the date of grant and the first anniversary of the date of grant and will become exercisable to the extent of 12,500 shares as of each of the second and third anniversaries of the date of grant.  See “Termination of Employment and Change-in-Control Arrangements – Meryl S. Golden” below for a discussion of certain provisions relating to the options granted to Ms. Golden.
Fiscal
Year
Reported
Summary Compensation
Table Total for CEO
Less:
 Reported
Value of Equity
Awards(a)
Plus:
Equity
Award
Adjustments(b)
Equals:
Compensation Actually Paid to CEO
2022$660,700$136,500$(588,500)$(64,300)
     
2021$1,921,435$1,386,500$1,066,762$1,601,697
      
(8) Represents amounts earned pursuant to the KICO employee bonus plan for 2020 and 2019._________

(a)The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” column in our Summary Compensation Table for the applicable year.
(b)The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; and (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value. There were no awards vested in the year they were granted. The amounts deducted or added in calculating the equity award adjustments are as follows:
(9) Represents employer matching contributions under our deferred compensation plan of $11,909, employer matching contributions under our defined contribution plan of $8,700 and a car allowance of $12,000.
Fair Value of Equity Awards for CEO20222021
As of year-end for unvested awards granted during the year$36,855$1,258,845
Year-over-year increase (decrease) of unvested awards granted in prior years$(671,932)$(192,083)
Increase (decrease) from prior fiscal year-end for awards granted in prior years that vested during the year$46,577$-0-
Total Equity Award Adjustments$(588,500)$1,066,762

(3)The dollar amounts reported represent the average of the amounts reported for our NEOs as a group (excluding our CEO) in the “Total” column of our Summary Compensation Table in each applicable year. The names of each of the NEOs (excluding our CEO) included for purposes of calculating the average amounts for each applicable year are Mses. Golden and Chen.

8
(10) Represents employer matching contributions under our deferred compensation plan of $17,025, employer matching contributions under our defined contribution plan of $8,495 and a car allowance of $12,000.
(4)The dollar amounts reported represent the average amount of “compensation actually paid” to the NEOs as a group (excluding our CEO), as computed in accordance with SEC rules. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding our CEO) during the applicable year. In accordance with the SEC rules, the following adjustments were made to average total compensation for the NEOs as a group (excluding our CEO) for each year to determine the compensation actually paid, using the same methodology described above in Note 2:

Fiscal
Year
Average Reported
Summary Compensation
Table Total for
Non-CEO NEOs
Less:
Average Reported
Value of
Equity Awards
Plus:
Average Equity
Award
Adjustments(a)
Equals:
Average Compensation
Actually Paid to
Non-CEO NEOs
2022$493,907$75,000$(31,627)$387,280
     
2021$542,622$123,770$92,830$511,682
_________

(a)The amounts deducted or added in calculating the total average equity award adjustments are as follows:
(11) Represents employer matching contributions under our defined contribution plan of $11,400 and a car allowance of $12,000.
Average Fair Value of Equity Awards for Non-CEO NEOs20222021
As of year-end for unvested awards granted during the year$20,250$95,930
Year-over-year increase (decrease) of unvested awards granted in prior years$(49,299)$(2,363)
Increase (decrease) from prior fiscal year-end for awards granted in prior years that vested during the year$(2.578)$(737)
Total Average Equity Award Adjustments$(31,627)$92,830

(5)The amounts shown in the table represent the Company’s Total Stockholder Return (“TSR”) on an assumed investment of $100 in our common stock over the indicated measurement period. Cumulative TSR is calculated by dividing (i) the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between our common stock price at the end and the beginning of the measurement period by (ii) our common stock price at the beginning of the measurement period.
(6)The dollar amounts reported represent the amount of net loss attributable to the Company as reflected in our audited financial statements for the applicable year.

(12) Represents employer matching contributions under our defined contribution plan of $3,077 and a car allowance of $3,200.Employment Contracts

(13) Represents employer payments pursuant to agreement and general release totaling $155,969, consulting fees pursuant to agreement totaling $96,500, matching contributions under our deferred compensation plan of $1,722, employer matching contributions under our defined compensation plan of $9,628 and a car allowance of $5,400.

(14) Represents employer matching contributions under our deferred compensation plan of $4,090, employer matching contributions under our defined compensation plan of $10,752 and a car allowance of $7,200.

(15) Represents employer payments pursuant to agreement and general release totaling $87,729, consulting fees pursuant to agreement totaling $10,058, and employer matching contributions under our defined compensation plan of $11,060.

(16) Represents employer matching contributions under our defined contribution plan.

Employment Contracts
Barry B. Goldstein

Employment Agreement in effect for the year ended December 31, 2019
On October 16, 2018, we entered into an amended and restated employment agreement with Mr. Goldstein which took effecteffective as of January 1, 2019 and which was scheduled to expire on December 31, 2021 (the “Amended and Restated Goldstein Employment Agreement”). Pursuant to the Amended and Restated Goldstein Employment Agreement, Mr. Goldstein stepped down as our Chief Executive Officer on January 1, 2019 and was named Executive Chairman of the Board.
Pursuant to the Amended and Restated Goldstein Employment Agreement, Mr. Goldstein was entitled to receive an annual base salary of $636,500 for the calendar year 2019. In addition, Mr. Goldstein was eligible to receive an annual performance bonus equal to 3% of our consolidated income from operations before taxes, exclusive of our consolidated net investment income (loss) and net realized gains (losses) on investments. In addition, pursuant to the Amended and Restated Goldstein Employment Agreement, Mr. Goldstein was entitled to a long-term compensation (“LTC”)  payment (which was a continuation of the previous terms under Mr. Goldstein’s 2017 employment agreement with us) of between $945,000 and $2,835,000 based on a specified minimum increase in our adjusted book value per share (as defined in the Amended and Restated Goldstein Employment Agreement) as of December 31, 2019 as compared to December 31, 2016 (with the maximum LTC payment being due if the average per annum increase was at least 14%). Pursuant to the Amended and Restated Goldstein Employment Agreement, Mr. Goldstein was entitled to receive a grant, under the terms of our 2014 Equity Participation Plan (the “2014 Plan”), during the first 30 days of January 2020 with respect to a number of shares of restricted stock determined by dividing $436,500 by the fair market value of our common stock on the date of grant. The January 2020 grant was to vest with respect to 50% of the award on each of December 31, 2020 and December 31, 2021 based on the continued provision of services through the applicable vesting date. Also, pursuant to the Amended and Restated Goldstein Employment Agreement, Mr. Goldstein was entitled to receive a grant, under the 2014 Plan, during the first 30 days of 2021, with respect to a number of shares of restricted stock determined by dividing $236,500 by the fair market value of our common stock on the date of grant. The January 2021 grant was to vest on December 31, 2021 based on the continued provision of services through such date.  The above stock grant provisions were superseded by the provisions of the Second Amended and Restated Goldstein Employment Agreement as discussed below.

Agreement in effect as of January 1, 2020
On October 14, 2019, we entered into a second amended and restated employment agreement with Mr. Goldstein which took effect as of January 1, 2020, and expiresexpired on December 31, 2022 (the “Second Amended and Restated Goldstein Employment Agreement”).

9

Pursuant to the Second Amended and Restated Goldstein Employment Agreement, Mr. Goldstein iswas entitled to receive an annual base salary of $500,000 and an annual bonus equal to 6% of our consolidated income from operations before taxes, exclusive of our consolidated net investment income (loss), net unrealized gains (losses) on equity securities and net realized gains (losses) on investments, up to a maximum of 2.5 times his base salary. In addition, pursuant to the Second Amended and Restated Goldstein Employment Agreement, Mr. Goldstein iswas entitled to receive an LTCa long-term compensation (“LTC”) payment of between $945,000 and $2,835,000 based on a specified minimum increase in our adjusted book value per share (as defined in the Second Amended and Restated Goldstein Employment Agreement) as of December 31, 2022, as compared to December 31, 2019 (with the maximum LTC payment being due if the average per annum increase is at least 14%).

Pursuant to the Third Amended Goldstein Employment Agreement (discussed below), Mr. Goldstein relinquished the right to receive the LTC. Pursuant to the Second Amended and Restated Goldstein Employment Agreement, Mr. Goldstein received a grant, under the terms of the 2014 Plan, during January 2020, of a number of shares of restricted stock determined by dividing $1,250,000 by the fair market value of our common stock on the date of grant. The January 2020 grant vested with respect to one-third of the award on each of the first anniversaryand second anniversaries of the grant date and will vest with respect to one-thirdone-sixth of the award on each of the second anniversary of the grant dateDecember 29, 2023 and on December 31, 202230, 2024, based on the continued provision of services through the applicable vesting date.such dates. Also pursuant to the Second Amended and Restated Goldstein Employment Agreement, Mr. Goldstein received a grant, under the terms of the 2014 Plan, during January 2021, of a number of shares of restricted stock determined by dividing $1,500,000 by the fair market value of our common stock on the date of grant. The January 2021 grant will vestvested with respect to one-half of the award on each of the first anniversary of the grant date and will vest with respect to one-fourth of the award on each of December 31, 202229, 2023 and December 30, 2024, based on the continued provision of services through the applicable vesting date.such dates. Further, pursuant to the Second Amended and Restated Goldstein Employment Agreement, Mr. Goldstein received in 2020, and 2021 and will be entitled to receive in 2022 a grant, under the terms of the 2014 Plan, of a number of shares of restricted stock determined by dividing $136,500 by the fair market value of our common stock on the date of grant. The 2020 grant vested with respect to one-third of the award on each of the first and second anniversaries of the grant date and will vest with respect to one-sixth of the award on each of December 29, 2023 and December 30, 2024, based on the continued provision of services through such dates. The 2021 grant vested with respect to one-half of the award on the first anniversary of the grant date and will vest with respect to one-thirdone-fourth of the award on each of the second anniversary of the grant dateDecember 29, 2023 and on December 31, 202230, 2024, based on the continued provision of services through the applicable vesting date.such dates. The 20212022 grant will vest with respect to one-half of the award on each of the first anniversary of the grant dateDecember 29, 2023 and on December 31, 2022 based on the continued provision of services through the applicable vesting date.  The 2022 grant will vest on December 31, 202230, 2024, based on the continued provision of services through such date.
dates.

See “Termination of Employment and Change-in-Control Arrangements – Barry B. Goldstein” below for a discussion of the provisions of the Second Amended Goldstein Employment Agreement and Restatedthe Third Amended Goldstein Employment Agreement with regard to payments due and the acceleration of stock grants in the event of the termination of Mr. Goldstein’s employment.employment under certain circumstances and/or in the event of a change in control.

Employment Agreement effective as of January 1, 2023

On June 27, 2022, we entered into a third amended and restated employment agreement with Mr. Goldstein which took effect as of January 1, 2023, and expires on December 31, 2024 (the “Third Amended Goldstein Employment Agreement”).

10

Pursuant to the Third Amended Goldstein Employment Agreement, Mr. Goldstein is entitled to receive an annual base salary of $500,000 and an annual bonus equal to 3% of our consolidated income from operations before taxes, exclusive of our consolidated net investment income (loss), net unrealized gains (losses) on equity securities and net realized gains (losses) on investments, up to a maximum of 1.25 times his base salary.

Meryl S. Golden

Employment Agreement effective as of January 1, 2021

We and Ms. Golden arewere parties to an amended and restated employment agreement dated as of August 27, 2019 (as amended, the “GoldenDecember 24, 2020 (the “Amended Golden Employment Agreement”). Pursuant to the Amended Golden Employment Agreement, which expiresexpired on December 31, 2022, Ms. Golden serves as our Chief Operating Officer and iswas entitled to receive an annual base salary of $500,000. In addition, pursuant to the Amended Golden Employment Agreement and the 2014 Plan, in September 2019, Ms. Golden was granted an option to purchase 50,000 shares of common stock which vesthas vested to the extent of 12,500 shares on each of the date of grant and each of the first, second and third anniversaries of the date of grant. Further, pursuant to the Amended Golden Employment Agreement and the 2014 Plan, in each of January 2021 and January 2022, Ms. Golden was granted 30,000 shares of restricted stockstock. The 2021 grant vested to the extent of 10,000 on each of the first and is entitledsecond anniversaries of the date of grant and will vest to receive in Januarythe extent of 10,000 shares on the third anniversary of the date of grant. The 2022 30,000grant vested to the extent of 10,000 shares on the first anniversary of restricted stock. Each suchthe date of grant vestsand will vest to the extent of 10,000 shares on each of the first, second and third anniversaries of the date of grant.

Employment Agreement effective as of January 1, 2023

On June 27, 2022, we entered into a second amended and restated employment agreement with Ms. Golden which took effect as of January 1, 2023, and expires on December 31, 2024 (the “Second Amended Golden Employment Agreement”).

Pursuant to the Second Amended Golden Employment Agreement, Ms. Golden is entitled to receive an annual base salary of $500,000 and an annual bonus equal to 3% of our consolidated income from operations before taxes, exclusive of our consolidated net investment income (loss), net unrealized gains (losses) on equity securities and net realized gains (losses) on investments, up to a maximum of 1.25 times her base salary. In addition, pursuant to the Second Amended Golden Employment Agreement, Ms. Golden received, under the terms of the 2014 Plan, a grant in January 2023, and is entitled to receive a grant, under the terms of the 2014 Plan, during January 2024, under certain circumstances, of a number of shares of restricted stock determined by dividing $136,500 by the fair market value of our common stock on the date of grant. The 2023 grant will vest with respect to one-half of the award on the first anniversary of the grant date and one-half of the award on December 31, 2024, based on the continued provision of services through such dates. The 2024 grant will vest on December 31, 2024, based on the continued provision of services through such date. In the event that we are precluded from making a grant in 2024, then instead Ms. Golden shall be entitled to receive a cash bonus of $136,500 for such year.

11

See “Termination of Employment and Change-in-Control Arrangements – Meryl S. Golden” below for a discussion of the provisions of the Amended Golden Employment Agreement and the Second Amended Golden Employment Agreement with regard to payments due and the acceleration of stock awards in the event of the termination of Ms. Golden’s employment.employment under certain circumstances and/or in the event of a change in control.

Outstanding Equity Awards atAt Fiscal Year-End

The following table sets forth certain information concerning exercisable and unexercisable stock options and unvested stock grants held by the above Named Executive Officers as of December 31, 2020.2022:

 
Option Awards
Stock Awards
 
Option Awards
Stock Awards
Name
Number of Securities Underlying
Unexercised
Options
Exercisable

Number of Securities Underlying Unexercised Options Unexercisable
Option
Exercise Price
Option Expiration Date
Number of Shares of
Stock
That Have Not Vested
Market
 Value of Shares of Stock That Have Not Vested
Equity Incentive Plan Awards: Number of Unearned Shares That Have Not VestedEquity Incentive Plan Awards: Market or Payout Value of Unearned Shares That Have Not Vested
Number of Securities Underlying
Unexercised
Options
Exercisable


Number of Securities Underlying Unexercised Options Unexercisable
Option
Exercise Price
Option Expiration Date
Number of Shares of
Stock
That Have Not Vested
Market
 Value of Shares of Stock That Have Not Vested
Equity Incentive Plan Awards: Number of Unearned Shares That Have Not Vested
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares That Have Not Vested
Barry B. Goldstein----174,622(1)$1,161,236-$-----211,391(1) $-$-
              
Meryl S. Golden25,00025,000(2)$8.729/25/24-$--$-50,000-$8.729/25/2451,600(2) $-$-
              
Victor J. Brodsky-26,064(3)$7.991/27/252,327(4)$15,475-$-
    7,288(5)$48,465-$-
       
Benjamin Walden7,000-$7.853/11/21-$--$-
-19,207(6)$7.882/7/25   
Sarah (Minlei) Chen----5,413(3) $-$-
____________________

(1)Such shares vested to the extent of 58,208 shares on January 3, 2021 and will vest to the extent of 58,207 shares on each of January 3, 2022 and 2023.
(1)Such shares will vest to the extent of 105,696 shares on December 29, 2023, and 105,695 shares on December 30, 2024.
(2)Such shares vested to the extent of 10,000 shares on each of January 3, 2023 and January 4, 2023, and will vest to the extent of 10,000 shares on each of January 3, 2024, January 4, 2024 and January 3, 2025 and 800 shares on each of December 13, 2023 and 2024.
(3)Such shares vested to the extent of 1,191 shares on January 28, 2023, and will vest to the extent of 1,432 shares on November 2, 2023, 1,190 shares on January 28, 2024, and 800 shares on each of December 13, 2023 and 2024.

(2)Such option is exercisable to the extent of 12,500 shares on each of September 25, 2021 and 2022.

(3)Such option is exercisable on January 27, 2022.

(4)Such shares vested on February 22, 2021.

(5)Such shares vested to the extent of 3,644 shares on April 10, 2021 and will vest to the extent of 3,644 shares on April 10, 2022.

(6)Such option is exercisable on February 7, 2022.

Termination of Employment and Change-in-Control Arrangements
Barry B. Goldstein

Pursuant to the SecondThird Amended and Restated Goldstein Employment Agreement, in the event that Mr. Goldstein'sGoldstein’s employment is terminated by us without cause, or he resigns for good reason (each as defined in the Second Amended and Restated Goldstein Employment Agreement)each such employment agreement), Mr. Goldstein would be entitled to receive his annual base salary bonus and LTC paymentbonus for the remainder of the term. In addition, in the event of Mr. Goldstein’s death, his estate would be entitled to receive his base salary, accrued bonus and accrued LTC payment through the date of death.  Further, in the event that Mr. Goldstein’s employment is terminated by us without causefor any reason, or he resigns for goodany reason, or, in the event of the termination of Mr. Goldstein’s employment due to disability or death, Mr. Goldstein’s granted but unvested restricted stock awards will vest.

12

Pursuant to the Third Amended Goldstein Employment Agreement, Mr. Goldstein would be entitled to receive, under certain circumstances, a payment equal to 3.821.5 times his then annual base salary the target LTC payment of $1,890,000 and his accrued bonus in the event of the termination of his employment within eighteen months following a change of control of our company.  the Company. In addition, pursuant to the 2014 Plan, Mr. Goldstein’s unvested restricted stock awards will vest in the event of a change of control of the Company.

Meryl S. Golden

Pursuant to the Second Amended Golden Employment Agreement, in the event that Ms. Golden’s employment is terminated by us without cause, or she resigns for good reason (each as defined in the Second Amended Golden Employment Agreement), Ms. Golden would be entitled to receive her annual base salary for the remainder of the term or for twelve months, whichever is sooner.later. In addition, pursuant to the 2014 Plan, in the event of a termination of employment due to the death or disability of Ms. Golden, or following a change of control of our company, the option and stock grants scheduled to vest on the next vesting date following such event shall vest under certain circumstancecircumstances notwithstanding such event. Further, in the event that Ms. Golden’s employment is terminated by us without cause, or she resigns for good reason, Ms. Golden’s granted but unvested restricted stock awards will vest.

Ms. Golden would be entitled to receive, under certain circumstances, a payment equal to 1.5 times her then annual base salary and her accrued bonus in the event of the termination of her employment within eighteen months following a change in control of our company.the Company. In addition, pursuant to the 2014 Plan, Ms. Golden’s outstanding restricted stock awards will vest in the event of a change of control of the Company.

Sarah (Minlei) Chen

Pursuant to the 2014 Plan, in the event of a termination of employment due to the death or disability of Ms. Chen, the stock grants scheduled to vest on the next vesting date following such event shall vest under certain circumstances notwithstanding such event. In addition, pursuant to the 2014 Plan, Ms. Chen’s outstanding restricted stock awards will vest in the event of a change of control of the Company.

DIRECTOR COMPENSATION

The following table sets forth certain information concerning the compensation of our non-employee directors for the fiscal year ended December 31, 2020:2022:
13


Name
Fees Earned or
Paid in Cash
 
Stock Awards(1)
 
Option Awards
 
 
Total
 
Fees Earned or
Paid in Cash
  
Stock Awards(1)
  
Option Awards
  
Total
 
 
 
 
 
            
William L. Yankus
$  90,000
$  40,000
 $- 
$  130,000
 $93,000  $40,000  $-  $133,000 
Floyd R. Tupper
$  85,000
$  40,000
 $- 
$  125,000
 $88,000  $40,000  $-  $128,000 
Carla A. D’Andre
$  75,000
$  40,000
 $- 
$  115,000
 $78,000  $40,000  $-  $118,000 
Timothy P. McFadden
$  75,000
$  40,000
 $- 
$  115,000
 $78,000  $40,000  $-  $118,000 
__________________

(1)Amounts reflect the aggregate grant date fair value of grants made in the fiscal year computed in accordance with stock-based accounting rules (FASB ASC Topic 718-Stock Compensation), excluding the effect of estimated forfeitures. Assumptions used in the calculations of these amounts are included in Note 12 to our Consolidated Financial Statements included in the Annual Report available electronically to our stockholders.

(1)Amounts reflect the aggregate grant date fair value of grants made in the fiscal year computed in accordance with stock-based accounting rules (FASB ASC Topic 718-Stock Compensation), excluding the effect of estimated forfeitures. Assumptions used in the calculations of these amounts are included in Note 12 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, available electronically to our stockholders.

The aggregate number of unvested restricted stock awards outstanding as of fiscal year end for each non-employee director is as follows:

Name
Unvested Restricted
Stock Awards (#)
Floyd R. Tupper5,7048,000
William L. Yankus
5,7048,000
Carla A. D’Andre
5,7048,000
Timothy P. McFadden
5,3038,000

Effective January 1, 2021, ourOur non-employee directors are entitled to receive annual compensation for their services as directors as follows:

$63,000;
an additional $25,000 for service as audit committee chair, an additional $20,000 for service as compensation committee chair, an additional $10,000 for service as investment committee chair, and an additional $15,000 for service as chair of other committees; and
$40,000 of our common stock determined by the closing stock price on the first business day of the year, which vest on the first anniversary of the grant date.
$50,000;
an additional $25,000 for service as audit committee chair, an additional $20,000 for service as compensation and finance committee chair, an additional $10,000 for service as investment committee chair, and an additional $15,000 for service as chair of other committees; and
$53,000 of our common stock determined by the closing stock price on the first business day of the year, which vest on the first anniversary of the grant date.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT

The following table sets forth certain information as of June 17, 202115, 2023, regarding the beneficial ownership of our shares of common stock by (i) each person who we believe to be the beneficial owner of more than 5% of our outstanding shares of common stock, (ii) each present director, (iii) each Named Executive Officer and (iv) all of our present executive officers and directors as a group.

Name and Address
of Beneficial Owner
Number of Shares
Beneficially Owned
Approximate
Percent of Class
   
Barry B. Goldstein
15 Joys Lane
Kingston, New York
715,908(1)
 6.7 %
 
    
    
Floyd R. Tupper
73,422(2)
  *
 
    
    
Victor J. Brodsky
41,223(3)
  *
 
    
    
Meryl S. Golden
25,000(4)
  *
 
    
    
Benjamin Walden
24,881
  *
 
    
    
William L. Yankus
23,791
  *
 
    
    
Carla A. D’Andre
21,941(5)
  *
 
    
    
Timothy P. McFadden
21,586(6)
  *
 
    
    
The TCW Group, Inc.
    on behalf of the TCW Business Unit
865 South Figueroa Street
Los Angeles, California
958,423(7)
  9.0%
   
Michael Doak
Griffin Highline Capital LLC
4514 Cole Avenue
Dallas, Texas
595,238(8)
 5.6%
 
    
    
All executive officers
and directors as a group
(7 persons)
881,648(1)(2)(4)(5)(6)
  8.2%
14


Name and Address
of Beneficial Owner
Number of Shares
Beneficially Owned
Approximate
Percent of Class
Barry B. Goldstein
15 Joys Lane
Kingston, New York
832,076 (1)7.7%
Floyd R. Tupper87,576 (2)*
Meryl S. Golden85,248 (3)*
William L. Yankus37,945*
Carla A. D’Andre36,095 (4)*
Timothy P. McFadden35,740*
Sarah (Minlei) Chen3,987*
Gregory Fortunoff
49 West 37th Street
New York, New York 10018
813,905 (5)7.6%
The TCW Group, Inc.
    on behalf of the TCW Business Unit
865 South Figueroa Street
Los Angeles, California
597,740 (6)5.6%
Michael Doak
Griffin Highline Capital LLC
4514 Cole Avenue
Dallas, Texas
595,238 (7)5.5%
All executive officers
and directors as a group
(8 persons)
1,118,667 (1)(2)(3)(4)10.4%

* Less than 1%.

(1)The information regarding Mr. Goldstein is based solely on publicly available information filed with the SEC. Includes (i) 73,168 shares of common stock owned by Mr. Goldstein'sGoldstein’s wife and (ii) 15,000 shares held in a retirement trust for the benefit of Mr. Goldstein. Mr. Goldstein has sole voting and dispositive power over 642,740758,908 shares of common stock and shared voting and dispositive power over 73,168 shares of common stock. The inclusion of the shares owned by Mr. Goldstein'sGoldstein’s wife and the retirement trust shall not be construed as an admission that Mr. Goldstein is, for purposes of Section 13(d) or 13(g) of the Exchange Act, the beneficial owner of such shares.
  
(2)Includes (i) 32,395 shares owned by Mr. Tupper’s wife, (ii) 6,675 shares held in a retirement trust for the benefit of Mr. Tupper and (iii) 810 shares held in a retirement trust for the benefit of Mr. Tupper'sTupper’s wife. Mr. Tupper has sole voting and dispositive power over 40,21754,371 shares of common stock and shared voting and dispositive power over 33,205 shares of common stock. The inclusion of the shares owned by Mr. Tupper'sTupper’s wife and the retirement trusts for the benefit of Mr. Tupper and his wife shall not be construed as an admission that Mr. Tupper is, for purposes of Section 13(d) or 13(g) of the Exchange Act, the beneficial owner of such shares.

15

  
(3)Includes 3,645 shares issuable upon the vesting of restricted stock within 60 days.
(4)Represents50,000 shares issuable upon the exercise of options that are exercisable currently.
  
(5)(4)Includes (i) 1,400 shares held in a retirement trust for the benefit of Ms. D’Andre and (ii) 10,000 shares held in a retirement trust for the benefit of Ms. D’Andre’s husband. Ms. D’Andre has sole voting and dispositive power over 11,94126,095 shares of common stock and shared voting and dispositive power over 10,000 shares of common stock. The inclusion of the shares owned by the retirement trust for the benefit of Ms. D'Andre’sD’Andre’s husband shall not be construed as an admission that Ms. D’Andre is, for purposes of Section 13(d) or 13(g) of the Exchange Act, the beneficial owner of such shares.
  
(6)(5)Includes 265The information regarding Gregory Fortunoff is based solely on Amendment No. 2 to Schedule 13G filed by such reporting person with the SEC on May 22, 2023 (the “Fortunoff 13G/A”). According to the Fortunoff 13G/A, such reporting person has sole voting and dispositive power over 618,905 shares issuable upon the vesting of restrictedcommon stock within 60 days.and shared voting and dispositive power over 195,000 shares of common stock. The Fortunoff 13G/A also indicates that Scott Fortunoff has sole voting and dispositive power over 244,500 shares of common stock and shared voting and dispositive power over 195,000 shares of common stock.
  
(7)(6)The information regarding The TCW Group, Inc. on behalf of the TCW Business Unit is based solely on Amendment No. 3 to Schedule 13G/A13G filed by such reporting person with the SEC on February 8, 2021January 25, 2023 (the “TCW 13G/A”). According to the TCW 13G/A, such reporting person has shared voting and dispositive power over the 958,423597,740 shares of common stock.
  
(8)(7)The information regarding Michael Doak (“Doak”) and Griffin Highline Capital LLC (“Griffin”) is based solely on aAmendment No. 4 to Schedule 13D filed by such reporting persons with the SEC on February 11, 2021November 15, 2022 (the “Doak/Griffin 13D”13D/A”). According to the Doak/Griffin 13D,13D/A, each of Doak and Griffin has shared voting and dispositive power over the 595,238 shares of common stock.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table sets forth information as of December 31, 2020 with respect to compensation plans (including individual compensation arrangements) under which our common stock is authorized for issuance, aggregated as follows:
● All compensation plans previously approved by security holders; and
● All compensation plans not previously approved by security holders.

EQUITY COMPENSATION PLAN INFORMATION
 
 
Number of securities to be issued upon exercise of outstanding options, warrants and rights
 
Weighted average exercise price of outstanding options, warrants and rights
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
 
(a)
 
(b)
 
(c)
 
Equity compensation plans approved by security holders119,966$8.26843,316(1)
    
Equity compensation plans not approved by security holders---
    
Total119,966$8.26843,316
The following table sets forth information as of December 31, 2022, with respect to compensation plans (including individual compensation arrangements) under which our common stock is authorized for issuance, aggregated as follows:

All compensation plans previously approved by security holders; and
All compensation plans not previously approved by security holders.

16

 Number of securities to be issued upon exercise of outstanding options, warrants and rightsWeighted average exercise price of outstanding options, warrants and rightsNumber of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
 (a)(b)(c)
Equity compensation plans approved by security holders107,201$8.31979,976(1)
    
Equity compensation plans not approved by security holders---
    
Total107,201$8.31979,976(1)

(1)Includes 370,964366,597 shares reserved for issuance pursuant to unvested restricted stock grants.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Dale A. Thatcher

In connection with the separation from employment of Dale Thatcher as our Chief Executive Officer and President in July 2019 (the “Thatcher Separation Date”), we entered into an Agreement and General Release (the “Thatcher Separation Agreement”) with Mr. Thatcher.  Pursuant to the Thatcher Separation Agreement, we agreed to provide the following payments and benefits to Mr. Thatcher in full satisfaction of all payments and benefits and other amounts due to him under the terms of his employment agreement with us (and the related KICO employment agreement) upon his separation from employment: (i) $381,111 (representing the amount of base salary he would have received had he remained employed through March 31, 2020), (ii) $5,000 in full satisfaction of any bonus payments payable under his employment agreement (and related KICO employment agreement), (iii) continuing group health coverage commencing on the Thatcher Separation Date and ending on March 31, 2020; and (iv) continued vesting of all stock awards previously granted to Mr. Thatcher in his capacity as an executive officer but which were unvested as of the Thatcher Separation Date.  Effective January 27, 2021, we entered into an agreement (the “Relinquishment Agreement”) with Mr. Thatcher.  Pursuant to the Relinquishment Agreement, Mr. Thatcher relinquished his right to receive 14,077 unissued Shares which vested on January 1, 2021, the right to receive 11,905 Shares which were scheduled to vest on March 14, 2021 and the right to receive 14,076 Shares which were scheduled to vest on January 1, 2022 in full consideration of the payment by the Company of an aggregate of $280,406.

In addition, we agreed to provide Mr. Thatcher with a severance payment of $20,000 in consideration for a release.  Pursuant to the Thatcher Separation Agreement, Mr. Thatcher agreed that, for a period of three years following the Thatcher Separation Date, he shall not accept any operating executive role with another property and casualty insurance company.

Victor Brodsky

In connection with the cessation of employment of Victor Brodsky as our Chief Financial Officer effective September 30, 2020 (the “Brodsky Separation Date”), we entered into an Agreement and General Release (the “Brodsky Separation Agreement”) with Mr. Brodsky.  Pursuant to the Brodsky Separation Agreement, we agreed to provide the following payments and benefits to Mr. Brodsky in full satisfaction of all payments and benefits and other amounts due to him upon his cessation of employment: (i) $155,969 (representing five months of base salary); (ii) continuing group health coverage commencing on October 1, 2020 and ending no later than February 28, 2021; and (iii) continued vesting of all granted but unvested stock and option awards as if Mr. Brodsky had remained in our employ.

Benjamin Walden

In connection with the cessation of employment of Benjamin Walden as Executive Vice President and Chief of Actuary of KICO effective September 30, 2020 (the “Walden Separation Date”), we entered into an Agreement and General Release (the “Walden Separation Agreement”) with Mr. Walden.  Pursuant to the Walden Separation Agreement, we agreed to provide the following payments and benefits to Mr. Walden in full satisfaction of all payments and benefits and other amounts due to him upon his cessation of employment: (i) an amount equal to the base salary he would have received had he remained employed through November 30, 2020 (with an extension thereof to December 31, 2020 under certain circumstances); (ii) continuing group health coverage commencing on the Walden Separation Date and ending no later than December 31, 2020; and (iii) the grant to Mr. Walden of an option to purchase 19,207 shares of common stock, which option vests two years from the date of grant.

Other
The daughter of Barry Goldstein, Amanda Goldstein, isRofsky, was employed during 2022 as our Investor Relations Director andDirector.  She no longer serves in that role.  Ms. Rofsky currently serves as Vice President of Cosi Agency, Inc., one of our subsidiaries.subsidiaries, and Lead Business Process Analyst for KICO. For the fiscal year ended December 31, 2020,2022, she earned $172,191$163,927 in compensation.

Related Party Transactions
Due to the infrequency of related party transactions, we have not formally adopted procedures for the review of, or standards for approval of, such transactions; however, our Board of Directors (or a designated committee thereof) will review related party transactions on a case-by-case basis.

PROPOSAL 1: ELECTION OF DIRECTORS

Six directors are to be elected at the meeting to serve until the next annual meeting of stockholders and until their respective successors shall have been elected and have qualified.

Our Restated Certificate of Incorporation provides for cumulative voting of shares for the election of directors. This means that each stockholder has the right to cumulate his votes and give to one or more nominees as many votes as equals the number of directors to be elected (six) multiplied by the number of shares he is entitled to vote. A stockholder may therefore cast his votes for one nominee or distribute them among two or more of the nominees.

Nominees for Directors

All of the nominees are currently members of our Board of Directors. The following table sets forth each nominee’s age as of June 17, 2021,15, 2023, the positions and offices presently held by him or her with us, and the year in which he or she became a director. The Board of Directors recommends a vote FOR all nominees. The person named as proxy intends to vote cumulatively all shares represented by proxies equally among all nominees for election as directors, unless proxies are marked to the contrary.
NameAgePositions and Offices HeldDirector Since
    
    
Barry B. Goldstein68Chief Executive Officer, President, Executive Chairman of the Board and Director2001
Meryl S. Golden61Chief Operating Officer and Director2020
Floyd R. Tupper66Secretary and Director2014
William L. Yankus61Director2016
Carla A. D’Andre65Director2017
Timothy P. McFadden59Director2018

17

NameAgePositions and Offices HeldDirector Since
    
Barry B. Goldstein70Chief Executive Officer, President, Executive Chairman of the Board and Director2001
Meryl S. Golden63Chief Operating Officer and Director2020
Floyd R. Tupper68Secretary and Director2014
Timothy P. McFadden61Director (Lead Independent Director)2018
William L. Yankus63Director2016
Carla A. D’Andre67Director2017
    
Barry B. Goldstein
Mr. Goldstein has served as our Chief Executive Officer and President, as well as Chief Executive Officer and President of Kingstone Insurance Company, our wholly-owned New York property and casualty insurer (“KICO”), since July 19, 2019. He previously served as our Chief Executive Officer, President and Chairman of the Board from March 2001 through December 31, 2018, and as Chief Executive Officer of KICO from January 2012 through December 2018 and as President of KICO from January 2012 through December 31, 2018.2018 and from July 2019 through September 2021. Mr. Goldstein has served as our Executive Chairman of the Board since January 1, 2019, and as one of our directors since March 2001. He served as our Chief Financial Officer from March 2001 to November 2007 and as our Treasurer from May 2001 to August 2013. Since January 2006, Mr. Goldstein has served as Chairman of the Board of KICO. He has served as Chairman of its Executive Committee since October 2019 (having previously served in such capacity from 2006 to 2018). Mr. Goldstein has served as Chief Investment Officer of KICO since August 2008. He was Treasurer of KICO from March 2010 through September 2010. Effective July 1, 2009, we acquired a 100% equity interest in KICO. Mr. Goldstein is a certified public accountant (inactive). Mr. Goldstein received his B.A. degree and M.B.A. from State University of New York at Buffalo. We believe that Mr. Goldstein’s extensive experience in the insurance industry, including his executive-level service with KICO since 2006, givegives him the qualifications and skills to serve as one of our directors.

Meryl S. Golden

Ms. Golden has served as our Chief Operating Officer since September 2019 and as one of our directors since March 2020. She has also served as Chief Operating Officer, a director and a member of the Executive Committee of KICO since September 2019.2019 and as its President since October 2021. Ms. Golden has over 25 years of experience in the insurance industry. She served as Northeast General Manager of Progressive Insurance from 2000 to 2004 (having served as Connecticut General Manager at Progressive from 1996 to 2000). Ms. Golden was Senior Vice President/General Manager at Liberty Mutual from 2005 to 2007. From 2007 to 2009, she was a Management Committee advisor to Bridgewater Associates, a hedge fund. Ms. Golden served as General Manager of North America for Earnix, a banking and insurance software company, from 2010 to 2018 and was Sales Manager, Insurance Solutions for Arity, a mobility and data analytics company founded by Allstate, from 2018 until September 2019. Ms. Golden received her B.S. degree in Accounting from the Wharton School of the University of Pennsylvania and her M.B.A. in Marketing and Finance from the University of Chicago. We believe that Ms. Golden’s executive level experience in the insurance industry gives her the qualifications and skills to serve as one of our directors.

18

Floyd R. Tupper

Mr. Tupper is a certified public accountant in New York City. For over 3040 years, Mr. Tupper has counseled high-net worth individuals by creating tax planning strategies to achieve their goals as well as those of their families. He has also helped small businesses by developing business strategies to meet their current and future needs. He began his career in public accounting with Ernst & Young LLP prior to becoming self-employed. Mr. Tupper holds an M.B.A. in Taxation from the New York University Stern School of Business and a B.S. degree from New York University. Mr. Tupper served as a director of KICO from 2006 to 2018 and has served as Chairman of its Audit Committee since 2006. From 1990 until 2010, Mr. Tupper served as a Trustee of The Acorn School in New York City. He was also a member of the school’s Executive Committee and served as its Treasurer from 1990 to 2010. Mr. Tupper is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He has served as one of our directors and ChairmanChair of our Audit Committee since June 2014 and as our Secretary since June 2015. We believe that Mr. Tupper’s accounting experience, as well as his service on the Board of KICO (including his service as ChairmanChair of its Audit Committee), give him the qualifications and skills to serve as one of our directors.

William L. Yankus

Mr. Yankus brings to the Board over 30 years’ experience in the insurance industry.  Since September 2015, Mr. Yankus has provided insurance-related consulting services through Pheasant Hill Advisors, LLC.  From 2011 to 2015, he was Managing Director – Investment Banking at Stern Agee where he focused on small and mid-sized insurers.  Mr. Yankus served as Managing Director-Insurance Research at Fox-Pitt, Kelton from 1993 to 2009 and then as Head of Insurance Research at its successor, Macquerie, from 2009 to 2010.  Mr. Yankus served as Vice President, Insurance Research at Conning & Company from 1985 to 1993.  He completed the CFA program in 1989 and passed the CT uniform CPA exam in 1984.  Mr. Yankus has served as one of our directors since March 2016, Chairman of our Compensation Committee since April 2017 and Chairman of our Investment Committee since February 2020.  He received his B.A. degree in Economics and Accounting from The College of the Holy Cross. We believe that Mr. Yankus’ executive level experience in the insurance industry gives him the qualifications and skills to serve as one of our directors.

Carla A. D’Andre

Ms. D’Andre has more than 40 years of experience in the insurance industry. Since 2009, Ms. D’Andre has been Chairman, CEO and President of D’Andre Insurance Group, Inc., which she co-founded. D’Andre Insurance Group, Inc. is the parent of two independent insurance agencies. Prior to co-founding D’Andre Insurance Group, Ms. D’Andre held executive-level roles at several companies in the insurance industry, including Executive Vice President, Head – Global Corporate Practice and Member – Partner’s Council at Willis Group Holdings plc, a multinational risk advisor, insurance brokerage and reinsurance brokerage company; Managing Director and Strategic Account Manager at AON Risk Services, a global provider of risk management solutions; Chief Operating Officer at XL Capital’s insurance and technology start-up firm, Inquis Logic Inc.; Member of Senior Management and Managing Director of Swiss Re New Markets and Director of Alternative Markets at Swiss ReAmerica, affiliates of Swiss Reinsurance Company Ltd, a global reinsurance company; Senior Vice President of Sedgwick North America, an insurance brokerage firm; and Vice President of Johnson & Higgins, an insurance brokerage firm. Ms. D’Andre serves in senior capacities in several insurance industry groups. In January 2019 she was elected by her peers to a three-year term as a member of The Institutes’ CPCU Society Leadership Council. She also serves as a member of the Executive Advisory Council of St. John’s University School of Risk Management, Insurance and Actuarial Science. She has served as one of our directors since May 2017 and currently serves as Chair of our Finance Committee. Ms. D’Andre has an M.B.A. from Pace University’s Lubin School of Business and a B.B.A. degree from St. John’s University’s School of Risk Management, Insurance and Actuarial Science. We believe that Ms. D’Andre’s extensive experience in multiple capacities in the insurance industry gives her the qualifications and skills to serve as one of our directors.
Timothy P. McFadden

Mr. McFadden has more than 2930 years of experience in the insurance industry. Since 2012, Mr. McFadden has served as CEO and President of State Farm Indemnity Auto Insurance Company and Senior Vice President of State Farm Insurance, Eastern Market Area. Since 2015, he has also served as CEO and President of State Farm Florida Fire Company. Mr. McFadden served as Senior Vice President of State Farm Insurance Companies, Southern Zone from 2008 to 2011 and Senior Vice President of State Farm Insurance Companies, Southern & Mid Atlantic Zones from 2011 to 2013. Prior to joining the insurance industry, he was a Captain in the United States Army. Mr. McFadden is a member of Stetson University’s College of Law Board of Overseers. He formerly served as a member of the Board of State Farm Indemnity Auto Insurance Company, Local Initiatives Support Corporation, American College Ethics Board, State Farm Florida Fire Company, Top Layer Reinsurance and Florida Council of 100. Mr. McFadden received his B.S. degree from the United States Military Academy at West Point and his J.D. from Stetson College of Law. He also completed the General Management Program at Harvard Business School and received his Chartered Life Underwriter Designation from The American College of Financial Services. Mr. McFadden has served as one of our directors andsince August 2018, served as Chair of our Nominating and Corporate Governance Committee from August 2018 to March 2023 and has served as Lead Independent Director and Chair of our Corporate Sustainability and Risk Management Committee since August 2018.March 2023. We believe that Mr. McFadden'sMcFadden’s executive level experience in the insurance industry gives him the qualifications and skills to serve as one of our directors.

19

William L. Yankus

Mr. Yankus brings to the Board over 30 years’ experience in the insurance industry. Since September 2015, Mr. Yankus has provided insurance-related consulting services through Pheasant Hill Advisors, LLC. From 2011 to 2015, he was Managing Director – Investment Banking at Stern Agee where he focused on small and mid-sized insurers. Mr. Yankus served as Managing Director-Insurance Research at Fox-Pitt, Kelton from 1993 to 2009 and then as Head of Insurance Research at its successor, Macquerie, from 2009 to 2010. Mr. Yankus served as Vice President, Insurance Research at Conning & Company from 1985 to 1993. He completed the CFA program in 1989 and passed the CT uniform CPA exam in 1984. Mr. Yankus has served as one of our directors since March 2016, served as Chair of our Compensation Committee from April 2017 to March 2023, has served as Chair of our Compensation and Finance Committee since March 2023 and served as Chair of our Investment Committee from February 2020 to August 2021. He received his B.A. degree in Economics and Accounting from The College of the Holy Cross. We believe that Mr. Yankus’ executive level experience in the insurance industry gives him the qualifications and skills to serve as one of our directors.

Carla A. D’Andre

Ms. D’Andre has more than 40 years of experience in the insurance industry and brings significant risk management expertise to the Board. Since 2009, Ms. D’Andre has been Chairman, CEO and President of D’Andre Insurance Group, Inc., which she co-founded. D’Andre Insurance Group, Inc. is a full service insurance brokerage firm and is the parent of two independent insurance agencies. Prior to co-founding D’Andre Insurance Group, Inc., Ms. D’Andre held executive-level roles at several companies in the insurance industry, including Willis Group Holdings plc, a multinational risk advisor, insurance brokerage and reinsurance brokerage company; AON Risk Services, a global provider of risk management solutions; Inquis Logic Inc., an insurance and technology start-up firm; Swiss Re New Markets and Swiss ReAmerica, affiliates of Swiss Reinsurance Company Ltd, a global reinsurance company; Sedgwick North America, an insurance brokerage firm; and Johnson & Higgins, an insurance brokerage firm. Ms. D’Andre is licensed in property and casualty and life and health insurance in multiple states. She is a member of the board of Resolution Enterprises LLC, a start-up affiliated with the NYPD Crime Stoppers Program, and serves on the Executive Advisory Council of St. John’s University School of Risk Management, Insurance and Actuarial Science. Ms. D’Andre previously served on The Institutes’ CPCU Society Leadership Council. She has served as one of our directors since May 2017, served as Chair of our Finance Committee from August 2017 to March 2023 and has served as Chair of our Nominating and Corporate Governance Committee since March 2023. Ms. D’Andre graduated from the FBI Citizen’s Academy Program, serving as a consultant and testifying witness on insurance matters.  She has an M.B.A. from Pace University’s Lubin School of Business and a B.B.A. degree from St. John’s University’s School of Risk Management, Insurance and Actuarial Science. We believe that Ms. D’Andre’s extensive experience in multiple capacities in the insurance industry gives her the qualifications and skills to serve as one of our directors.

Family Relationships

There are no family relationships among any of our executive officers and directors.

20

Term of Office

Each director will hold office until the next annual meeting of stockholders and until his or her successor is elected and qualified or until his or her earlier resignation or removal. Each executive officer will hold office until the initial meeting of the Board of Directors following the next annual meeting of stockholders and until his or her successor is elected and qualified or until his or her earlier resignation or removal.

Board Diversity

Board Diversity Matrix (as of June 15, 2023)
Board Size:
Total Number of Directors:6
 FemaleMale
Part I: Gender Identity
Directors24
Part II: Demographic Background
White24

Committees
 
Audit Committee
 
The Audit Committee of the Board of Directors is responsible for overseeing our accounting and financial reporting processes and the audits of our financial statements.  The responsibilities and duties of the Audit Committee include the following:
 
assist the Board of Directors in fulfilling its responsibilities by reviewing the financial reports provided by us to the Securities and Exchange Commission, our stockholders or to the general public, and our internal financial and accounting controls,controls;

oversee the appointment, compensation and retention of, and the work performed by, any independent public accountants engaged by us,us;

recommend, establish and monitor procedures designed to improve the quality and reliability of the disclosure of our financial condition and results of operations,operations;

recommend, establish and monitor procedures designed to facilitate:

the receipt, retention and treatment of complaints relating to accounting, internal accounting controls or auditing matters,matters; and

21

the receipt of confidential, anonymous submissions by employees of concerns regarding questionable accounting or auditing matters.
 
The members of our Board’s Audit Committee currently are Messrs. Tupper (chair), Yankus and McFadden.  Our Board has adopted a written charter for the Audit Committee.  A copy of the charter is available on our website, www.kingstonecompanies.com.

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee of the Board of Directors is responsible for assisting the Board in identifying and recruiting qualified individuals to become Board members, selecting director nominees to be presented for Board and/or stockholder approval, identifying members of the Board to serve on each Board committee, and developing corporate governance guidelines.

The members of the Nominating and Corporate Governance Committee currently are Ms. D’Andre (Chair) and Messrs. McFadden and Tupper and Ms. D’Andre.Tupper. Our Board has adopted a written charter for the Nominating and Corporate Governance Committee. A copy of the charter is available on our website, www.kingstonecompanies.com.

The Nominating and Corporate Governance Committee considers, among other things, diversity of background, experience, skills, expertise, personal and professional integrity, character, business judgment, time availability and conflicts of interest in evaluating prospective Board members.   The Nominating and Corporate Governance Committee Charter requires that the Nominating and Corporate Governance Committee ensure that the initial list of candidates from which new independent director nominees are chosen by the Board include at least one candidate who is a person of color and one candidate who is female.  The Nominating and Corporate Governance Committee will consider qualified director candidates recommended by stockholders if such recommendations are provided in accordance with the procedures set forth in the section entitled “Stockholder Proposals - Stockholder Nominees” below.  The Nominating and Corporate Governance Committee evaluates all candidates based upon the considerations discussed above, as well as ‘independence’ (for purposes of compliance with the rules of the SEC and the NASDAQ Marketplace Rules).  After conducting an initial evaluation of a prospective nominee, the Nominating and Corporate Governance Committee will interview that candidate if it believes the candidate might be suitable to be a director. The Nominating and Corporate Governance Committee may also ask the candidate to meet with management.  If the Nominating and Corporate Governance Committee believes a candidate would be a valuable addition to our Board of Directors, it may recommend to the full Board that candidate'scandidate’s nomination and election.  At this time, except as discussed above, the Nominating and Corporate Governance Committee has not adopted minimum criteria for consideration of a proposed candidate for nomination.  The Board has determined that no independent director will serve for more than a total of 20 years in that capacity, unless otherwise determined by the Board, and that any independent director who reaches age 75 while serving as a director must retire from the Board effective at the end of his or her then current term, unless otherwise determined by the Board.

22

Compensation and Finance Committee

The Compensation and Finance Committee of the Board of Directors is responsible for the management of our business and affairs with respect to the compensation of our employees.  The responsibilities and duties of the Compensation and Finance Committee include the following:

review and approve the compensation of our Chief Executive Officer,Officer;

make recommendations to our Board regarding the compensation of all other executive officers,officers;

review, and make recommendations to our Board regarding, incentive compensation plans and equity-based plans, and where appropriate or required, recommend for approval by our stockholders, which includes the ability to adopt, amend and terminate such plans,plans;

administer our incentive compensation plans and equity-based plans, including designating the employees to whom awards are to be granted, the amount of the award or equity to be granted and the terms and conditions applicable to each award or grant, subject to the provisions of each plan,plan;

review, and make recommendations to our Board regarding, employment agreements and severance arrangements or plans, including any benefits to be provided in connection with a change in control, for our Chief Executive Officer and other executive officers, which includes the ability to adopt, amend and terminate such agreements, arrangements or plans,plans;

review, and make recommendations to our Board regarding, all employee benefit plans, which includes the ability to adopt, administer, amend and terminate such plans,plans;

review director compensation for service on our Board and Board committees and recommend any changes to our Board.Board;

review and make recommendations to our Board with regard to the following matters:

our annual capital plan, including capital allocation, funding and capital expenditures;

possible changes to our capital structure, including proposed equity and debt issuances, redemptions and repurchases;

proposed credit facilities, letters of credit, borrowings and guarantees;

any significant financial exposures or contingent liabilities;

23

the financial aspects of our corporate insurance programs.

The members of the Compensation and Finance Committee currently are Messrs. Yankus (Chair) and Tupper and Ms. D’Andre. Our Board has adopted a written charter for the Compensation and Finance Committee. A copy of the charter is available on our website, www.kingstonecompanies.com.

The Compensation and Finance Committee may form and delegate authority to subcommittees and may delegate authority to one or more designated members of the Compensation and Finance Committee. Our Chief Executive Officer assists the Compensation and Finance Committee from time to time by advising on a variety of compensation matters, such as assisting the Compensation and Finance Committee in determining appropriate salaries and bonuses for our executive officers. The Compensation and Finance Committee has the authority to consult with management and to engage the services of outside advisors, experts and others to assist it in its efforts.

Board Leadership Structure and Role in Risk Oversight

Our Board of Directors as a whole is responsible for our risk oversight.  Our executive officers address and discuss with our Board of Directors our risks and the manner in which we manage or mitigate such risks. While our Board of Directors has the ultimate responsibility for our risk oversight, our Board of Directors works in conjunction with its committees on certain aspects of its risk oversight responsibilities.  In particular, our Corporate Sustainability and Risk Management Committee oversees and makes recommendations to our Board with regard to our overall approach to risks related to business operations, including insurance underwriting and claims; reinsurance; catastrophe risk and the impact of changing climate conditions; credit risk in insurance operations; and information technology, including cybersecurity.  In addition, our Audit Committee focuses on financial reporting risks and related controls and procedures, and our Compensation and Finance Committee strives to create compensation practices that do not encourage excessive levels of risk taking that would be inconsistent with our strategies and objectives.

Since January 2019, Barry B. Goldstein has served as our Executive Chairman of the Board, having served from 2001 through 2018 as our Chairman of the Board. Mr. Goldstein served as our Chief Executive Officer from 2001 through 2018 and has served in such capacity since July 2019.  We do not currently have a lead independent director.  At this time,

Since March 2023, Timothy P. McFadden has served as our Lead Independent Director.  In such capacity, Mr. McFadden has the following duties and responsibilities:

preside at meetings of the Board of Directors believes that Mr. Goldstein’s combined role as Chief Executive Officer and Executiveat which the Chairman of ourthe Board enables us to benefit from Mr. Goldstein’s significant institutional and industry knowledge and experience, while atis not present, including executive sessions of the same time promoting unified leadership and direction for ourindependent directors;

serve as a liaison between the Chairman of the Board and executive management without duplicationthe independent directors;

24

preview the information to be provided to the Board;

approve meeting agendas for the Board;

assure that there is sufficient time for discussion of effortall meeting agenda items;

organize and cost.  Given our history, position, Board compositionlead the Board’s evaluation of the CEO;

be responsible for leading the Board’s annual self-assessment;

have authority to call meetings of the independent directors; and the relatively small size of our company

if requested by stockholders, be available for consultation and management team, at this time, our Board believes that we and our stockholders are best served by our current leadership structure.direct communication.

Report of the Audit Committee

In overseeing the preparation of the financial statements of the Company as of December 31, 20202022, and for the years ended December 31, 20202022 and 2019,2021, the Audit Committee met with management to review and discuss all financial statements prior to their issuance and to discuss significant accounting issues. Management advised the Audit Committee that all financial statements were prepared in accordance with generally accepted accounting principles, and the Audit Committee discussed the statements with management. The Audit Committee also discussed with Marcum LLP (“Marcum”), our outside auditors, the matters required to be discussed by Public Company Accounting Oversight Board’s Auditing Standard No. 1301, Communications with Audit Committees, as currently in effect.

The Audit Committee received the written disclosures and the letter from Marcum required by applicable requirements of the Public Company Accounting Oversight Board regarding Marcum’s communications with the Audit Committee concerning independence and the Audit Committee discussed Marcum’s independence with Marcum.

On the basis of these reviews and discussions, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020,2022, for filing with the Securities and Exchange Commission.

Members of the Audit Committee

Floyd R. Tupper (chair)
William L. Yankus
Timothy P. McFadden

Meetings

Our Board of Directors held thirteen25 meetings during the fiscal year ended December 31, 2020.2022.

25

The Audit Committee of the Board of Directors held ninefour meetings during the fiscal year ended December 31, 2020.2022.

The Nominating and Corporate Governance Committee of the Board of Directors held two meetingsone meeting during the fiscal year ended December 31, 2020.2022.

The Compensation Committee of the Board of Directors held twofour meetings during the fiscal year ended December 31, 2020.2022.

During 2020,2022, all of our then directors attended at least 75% of the aggregate of the total number of meetings of the Board and the total number of the meetings of the committees of the Board on which they served, except that Jay M. Haft, who retired as a director in April 2020, attended one of the four Board meetings that occurred in 2020 while he was a director.served.

We do not have a formal policy regarding director attendance at our annual meeting of stockholders. However, all directors are encouraged to attend. EachNone of our directors was in attendance atattended last year’s annual meeting of stockholders.

Communications with Board of Directors

Any security holder who wishes to communicate with our Board of Directors or a particular director should send the correspondence to the Board of Directors, Kingstone Companies, Inc., 15 Joys Lane, Kingston, New York 12401, Attention: Corporate Secretary. Any such communication so addressed will be forwarded by the Corporate Secretary to the Lead Independent Director, the members or a particular member of the Board.Board, as the case may be.

Audit Committee Financial Expert

Our Board of Directors has determined that Mr. Tupper isqualifies as an “audit committee financial expert,” as that term is defined in Item 407(d)(5) of Regulation S-K. Mr. Tupper is an “independent director” based on the definition of independence in Listing Rule 5605(a)(2) of The Nasdaq Stock Market.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16 of the Exchange Act requires that reports of beneficial ownership of common stock and changes in such ownership be filed with the Securities and Exchange CommissionSEC by Section 16 “reporting persons,” including directors, certain officers, holders of more than 10% of the outstanding common stock and certain trusts of which reporting persons are trustees. We are required to disclose in this proxy statement each reporting person whom we know to have failed to file any required reports under Section 16 on a timely basis during the fiscal year ended December 31, 2020.2022. To our knowledge, based solely on a review of copies of Forms 3, 4 and 5 filed with the Securities and Exchange CommissionSEC and written representations that no other reports were required, during the fiscal year ended December 31, 2020,2022, our officers, directors and 10% stockholders complied with all Section 16(a) filing requirements applicable to them, ,exceptexcept that Victor Brodsky, formerly our Chief Financial Officer and Treasurer,Ms. Golden filed one Form 4 late reporting two transactions, Richard Swartz, our Chief Accounting Officer, filed his Form 3 late and filed two Forms 4 late, reporting a total of three transactions, and Mr. Goldstein filed a Form 5 late, reporting(reporting one gift transaction.transaction).

26

Director Independence

Board of Directors

Our Board of Directors is currently comprised of Barry B. Goldstein, Floyd R. Tupper, William L. Yankus, Carla A. D’Andre, Timothy P. McFadden and Meryl S. Golden. Our board of directors has determined that each of Messrs. Tupper, Yankus and McFadden and Ms. D’Andre is independent under applicable Nasdaq listing standards and federal securities rules and regulations.

Audit Committee

The members of our Board’s Audit Committee currently are Messrs. Tupper (Chair), Yankus and McFadden, each of whom is an “independent director” basedindependent under applicable Nasdaq listing standards and federal securities rules and regulations on the definitionindependence of independence in Listing Rule 5605(a)(2) of The Nasdaq Stock Market and Rule 10A-3(b)(1) under the Exchange Act.Audit Committee members.

Nominating and Corporate Governance Committee

The members of our Board’sthe Nominating and Corporate Governance Committee currently are Ms. D’Andre (Chair) and Messrs. McFadden and Tupper, each of whom is independent under applicable Nasdaq listing standards and federal securities rules and regulations on independence.

Compensation and Finance Committee

The members of the Compensation and Finance Committee currently are Messrs. Yankus (Chair) and Tupper and Ms. D’Andre, each of whom is independent under applicable Nasdaq listing standards and federal securities rules and regulations on independence.
Compensation Committee
The members of our Board’s Compensation Committee currently are Messrs. Yankus and Tupper and Ms. D’Andre, each of whom is independent under applicable Nasdaq listing standards and federal securities rules and regulations on independence.

Recommendation

The Board of Directors recommends a vote FOR all nominees.


PROPOSAL 2: RATIFICATIONAPPROVAL OF SELECTIONAN AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED 2014 EQUITY PARTICIPATION PLAN TO INCREASE THE NUMBER OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMSHARES OF COMMON STOCK AUTHORIZED TO BE ISSUED PURSUANT TO THE PLAN FROM 1,400,000 TO 1,900,000

The Audit Committee of our
Our Board of Directors has selected Marcum LLP as our independent registered public accounting firmapproved the adoption of an amendment to examine our financial statements for the year ending December 31, 2021.
Although ratification by stockholders is not required by our organizational documentsCompany’s Amended and Restated 2014 Equity Participation Plan (the “2014 Plan” or other applicable law, our Boardthe “Plan”) to increase the number of Directors has determined that requesting ratification by stockholders of the appointment of Marcum as our independent registered public accounting firm for the fiscal year ending December 31, 2021 is a matter of good corporate practice.  If stockholders do not ratify the selection, the Audit Committee may reconsider whether or not to retain Marcum, but may still determine to retain them.  Even if the selection is ratified, the Audit Committee, in its discretion, may change the appointment at any time during the year if it determines that such a change would be in the best interests of us and our stockholders.
Marcum has served as our independent registered public accountants with respect to each fiscal year since the year ended December 31, 2013.

It is not expected that a representative of Marcum will attend the meeting.
The following is a summary of the fees billed to us by Marcum LLP, our independent auditors, for professional services rendered for the fiscal years ended December 31, 2020 and 2019.
Fee Category
 
Fiscal 2020 Fees
 
Fiscal 2019 Fees
Audit Fees(1)
 $241,535
 $306,940 
Tax Fees(2)
 $-
 $- 
Audit-Related Fees(3)
 $-
 $- 
All Other Fees(4)
 $- 
 $-  
 
 $241,535 
 $306,940 

(1)Audit Fees consist of fees billed for services rendered for the audit of our consolidated financial statements and review of our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q, and services provided in connection with other statutory or regulatory filings.
(2)Marcum did not provide any tax services during the fiscal year.
(3)Marcum did not provide any “Audit-Related” services during the fiscal year.
(4)Marcum did not provide any other services during the fiscal year.

The Audit Committee is responsible for the appointment, compensation and oversight of the work of the independent auditors and approves in advance any services to be performed by the independent auditors, whether audit-related or not. The Audit Committee reviews each proposed engagement to determine whether the provision of services is compatible with maintaining the independence of the independent auditors. Substantially all of the fees shown above were pre-approved by the Audit Committee.
Vote Required

The ratification of the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021 requires the affirmative vote of stockholders who hold a majority of the shares of common stock present in person or represented by proxy atauthorized to be issued under the meeting and entitled2014 Plan from 1,400,000 to vote.1,900,000 (the “Plan Amendment”).  The Plan Amendment is being submitted to the stockholders for approval.

Recommendation
The Board of Directors recommends a vote FOR the ratification of the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.

PROPOSAL 3:  APPROVAL OF THE KINGSTONE COMPANIES, INC.
EMPLOYEE STOCK PURCHASE PLAN

We are seeking your vote to approve the Kingstone Companies, Inc. Employee Stock PurchaseThe 2014 Plan (the “ESPP”). The ESPP was approved andoriginally adopted by our Board on June 19, 2021, subjectAugust 12, 2014, pursuant to which up to 700,000 shares of common stock were authorized to be issued.  Stockholder approval by the stockholders at the Annual Meeting, and will become effective upon receiving stockholder approval at the Annual Meeting.

The purpose of the ESPP is to provide eligible employees of the Company and certain of its subsidiaries an opportunity to use payroll deductions to purchase shares of2014 Plan was obtained on August 11, 2015.  On May 27, 2020, our common stock and thereby acquire an ownership interest in the Company. The ESPP is intended to qualify as an “employee stock purchase plan” meeting the requirements of Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”).

The maximum aggregate number of shares of our common stock that may be purchased under the ESPP will be 750,000 shares, subject to adjustment as provided for in the ESPP. The share pool for the ESPP represents 7.0% of the total number of shares of our common stock outstanding as of June 17, 2021. In determiningBoard increased the number of shares authorized to reservebe issued under the 2014 Plan from 700,000 to 1,400,000, among other amendments. Stockholder approval of the increase and other amendments was obtained on August 5, 2020.  On May 10, 2023, our Board increased the number of shares authorized to be issued under the 2014 Plan from 1,400,000 to 1,900,000, subject to stockholder approval of the Plan Amendment.

27

As of June 15, 2023, options for the ESPP,purchase of 163,951 shares of common stock (net of cancellations) had been granted pursuant to the 2014 Plan.  In addition, as of such date, 1,151,071 shares of restricted stock had been granted pursuant to the 2014 Plan and 84,978 shares were reserved for future grants under the 2014 Plan (without giving effect to the Plan Amendment increasing the number of shares authorized to be issued under the 2014 Plan to 1,900,000).  See “Plan Benefits” below for additional details.

The Plan plays an important role in our efforts to attract and retain employees of outstanding ability and to align the interests of employees with those of the stockholders through increased stock ownership.  In order to continue to provide appropriate equity incentives to employees in the future, our Board of Directors considered the potential dilutive impact to stockholders and the anticipated employee participation ratehas approved an increase in the ESPP.number of authorized shares under the Plan.  As discussed below, the Plan is also designed to provide incentives to our non‑employee directors, consultants and advisors.

The following statements include summaries of material termscertain provisions of the ESPP.Plan.  The statements do not purport to be complete and are qualified in their entirety by reference to the provisions of the ESPP,Plan, a copy of which is available at our offices and has been included as an exhibit to our Current Report on Form 8-K filed with this proxy statement as Appendix A.the Securities and Exchange Commission on June 1, 2020.

Purpose
Authorized Shares
The purpose of the Plan is to advance our interests by inducing individuals or entities of outstanding ability and potential to join and remain with, or provide consulting or advisory services to, us by encouraging and enabling eligible employees, non-employee directors, consultants and advisors to acquire proprietary interests in our company, and by providing the participating employees, non-employee directors, consultants and advisors with an additional incentive to promote our success.

Administration

The Plan provides for its administration by our Board or by a committee (the “Committee”) consisting of at least two persons chosen by the Board each of whom is intended to be an “outside independent director” to the extent required by the rules and regulations of any established stock market exchange or national market system, including, without limitation, The Nasdaq Stock Market.  The following discussion of the Plan assumes that the Plan is administered by the Committee.

The Committee has authority to select from the group of eligible employees, non-employee directors, consultants and advisors the individuals or entities to whom awards will be granted under the Plan, and to determine the times at which awards will be granted and the terms of such grants, subject to certain restrictions as set forth in the Plan.  The Committee is authorized to interpret the Plan and the interpretation and construction by the Committee of any provision of the Plan or of any award granted under the Plan shall be final and conclusive.  The receipt of awards under the Plan by any members of the Committee shall not preclude their vote on any matters in connection with the administration or interpretation of the Plan.

28

Eligibility

Subject to adjustmentcertain limitations as providedset forth in the ESPP, a totalPlan, options to purchase shares may be granted thereunder to persons or entities who, in the case of 750,000 sharesincentive stock options, are employees of our common stock will be made available for sale under the ESPP. In the event of a stock dividend, stock splitcompany or, combination of shares, recapitalization or other change in the Company’s capitalization,case of nonstatutory stock options, are employees or other distribution with respectnon‑employee directors of, or certain consultants or advisors to, our stockholders other than normal cash dividends, an automatic adjustment will be made in a manner that complies with Section 423 of the Codecompany.  Subject to certain limitations as set forth in the numberPlan, stock appreciation rights and kindstock bonus awards may be granted thereunder to persons or entities who are employees or non-employee directors of, shares asor certain consultants or advisors to, which outstanding options then unexercised will be exercisable, in the available shares reserved for sale under the ESPP, and in the purchase period limit, in order to maintain the proportionate interest of the participants before and after the event.us.

As of June 17, 2021,15, 2023, 88 employees, our four non-employee directors, and persons providing certain consulting services to us were eligible to receive awards under the closingPlan.

Options

Nature of Options

The Committee may grant options under the Plan which are intended to either qualify as “incentive stock options” within the meaning of Section 422 of the Internal Revenue Code of 1986 (the “Code”) or not so qualify.  We refer to options that do not so qualify as “nonstatutory stock options.” The Federal income tax consequences relating to the grant and exercise of incentive stock options and nonstatutory stock options are described below under “Federal Income Tax Consequences.”

Option Price

The option price of ourthe shares subject to an incentive stock option or a nonstatutory stock option may not be less than the fair market value (as such term is defined in the Plan) of the common stock on the Nasdaq Stock Market was $8.21 per share.

Plan Administration

Our Board or any committee designated by the Board (the “Administrator”) will administer the ESPP, and will have full and exclusive authority to interpret the terms of the ESPP and determine eligibility to participate, subject to the conditions of the ESPP.

Eligibility

Generally, employees of the Company and any of its designated subsidiaries are eligible to participatedate upon which such option is granted.  In addition, in the ESPP, subject tocase of a recipient of an incentive stock option who, at the procedural enrollment and other requirements intime the ESPP. However, pursuant to the ESPP, the following employees will not be eligible to participate: (i)  employees have not completed at least one year of service since their last hire date, (ii) employees who customarily work notoption is granted, owns more than twenty hours per week, and (iii) employees who customarily work not more than five months per calendar year.

No employee may be granted options to purchase shares of our common stock under the ESPP if such employee (i) immediately after the grant would own capital stock possessing 5% or more10% of the total combined voting power or value of all classes of our capital stock or (ii) holds rights to purchase sharesof a parent or of any of our common stock under all of our employee stock purchase plans (as defined in Section 423subsidiaries, the option price of the Code) that accrueshares subject to such option must be at a rate that exceeds $25,000 worth of shares of our common stock for each calendar year.

As of June 17, 2021, approximately 71 employees would be eligible to participate in the ESPP.

Offering Periods

Pursuant to the termsleast 110% of the ESPP, onfair market value of the first trading day of an offering period, each eligible employee will be granted an option to purchase shares of our common stock on the last day ofdate upon which such offering period. The Administrator will determine the length of the offering periods which will not exceed 27 months. If the ESPPoption is approved at the Annual Meeting, it is anticipated that the first offering period will commence during 2021.granted.

Contributions

The ESPP permits each participant to purchase shares ofOn June 21, 2023, the last reported sale price for our common stock, through payroll deductionsas reported by The Nasdaq Stock Market, was $1.35 per share.

Exercise of up to 15% of his or her eligible compensation; provided, however, that a participant may not purchase more than 5,000 shares of our common stock during each offering period, subject to adjustment as provided in the ESPP. No interest will accrue on a participant’s contributions to the ESPP. A participant may decrease (but not increase) the rate of his or her contributions once per offering period. A participant’s payroll deduction authorization will remain in effect for subsequent offering periods unless the participant’s participation in the ESPP terminates or the participant withdraws from an offering period, as described below.Options

Purchases

Unless a participant terminates employment or withdraws fromAn option granted under the ESPP or an offering period before the last trading day of an offering period, the participant’s option will automaticallyPlan shall be exercised onby the last trading daydelivery by the holder to our Secretary at our principal office of each offering period. Thea written notice of the number of shares with respect to which the option is being exercised. The notice must be accompanied, or followed within ten days, by payment of ourthe full option price of such shares which must be made by the holder’s delivery of (i) a check in such amount, (ii) previously acquired common stock, purchased will be determined by dividing the payroll contributions accumulated in the participant’s account by the applicable purchase price; provided, however, that a participant may not purchase more than 5,000 shares of our common stock during each offering period, subject to adjustment as provided in the ESPP. No fractional shares of our common stock will be purchased. Any contributions accumulated in a participant’s account which are not sufficient to purchase a full share of our common stock will be refunded to the participant, without interest.

Until otherwise determined by the Administrator, the purchase price of the shares during each offering period will be 85% of the lower of (i) the fair market value per share of ourwhich shall be determined as of the date of exercise, or (iii) if provided for in a stock option agreement pursuant to which the option is granted, and subject to applicable law, a check in an amount equal to the par value of the common stock onbeing acquired and a promissory note in an amount equal to the first trading daybalance of each offering periodthe exercise price, or a combination of (i), (ii) and (iii).  Alternatively, if provided for in the award agreement, the holder may elect to have us reduce the number of shares otherwise issuable by a number of shares having a fair market value per shareequal to the exercise price of our common stock on the last trading day the offering period (which we refer to as the “purchase date”).option being exercised.

29

Duration of Options

Withdrawals; Termination of Employment

A participant may end his or her participation at any time during an offering period and all, but not less than all, of his or her accrued contributions not yet used to purchase shares of our common stock will be returned to him or her, as soon as administratively practicable. If a participant withdraws from an offering period, he or she must re-enroll in the ESPP in order to re-commence participation in a subsequent offering period.

If a participant ceases to be an eligible employee for any reason, he or she will be deemed to have elected to withdraw from the ESPP and his or her contributions not yet used to purchase shares of our common stock will be returned to him or her, as soon as administratively practicable.

Stockholder Rights

No participant will have any voting, dividend, or other stockholder rights with respect to shares of commonincentive stock subject to any option granted under the ESPP until such shares have been purchased and deliveredPlan shall be exercisable after the expiration of ten years from the date of its grant. However, if an incentive stock option is granted to a 10% stockholder, the participant.option shall not be exercisable after the expiration of five years from the date of its grant.

Nonstatutory stock options granted under the Plan shall be exercisable for a period of up to ten years from the date of their grant.

Non-Transferability

A participant mayOptions granted under the Plan are not assign, transfer, pledge ortransferable otherwise dispose of in any way (other than by will or the laws of descent and distribution)distribution and such options are exercisable, during a holder’s lifetime, only by the grantee; provided, however, that a nonstatutory stock option granted under the Plan may, upon the approval of the Committee be transferred in whole or in part during a grantee’s lifetime to certain family members of a grantee through a gift or domestic relations offer.

Death, Disability or Termination of Employment

Subject to the terms of the agreement pursuant to which the options are granted, if the employment of an employee or the services of a non-employee director, consultant or advisor shall terminate other than by reason of death or disability, such option may be exercised at any time within three months after such termination, but in no event after the expiration of the option.

Subject to the terms of the agreement pursuant to which the options are granted, if an option holder under the Plan (i) dies while employed by us or while serving as a non‑employee director of, or consultant or advisor to, us, or (ii) dies within three months after the termination of his or her rights with regard to options granted underemployment or services for any reason, then such option may be exercised by the ESPPestate of the employee, non‑employee director, consultant or contributions credited toadvisor, or by a person who acquired such option by bequest or inheritance from the deceased option holder, at any time within one year after his or her account.death.

Subject to the terms of the stock option agreement pursuant to which the options are granted, if the holder of an option under the Plan ceases employment or services because of permanent and total disability (within the meaning of Section 22(e)(3) of the Code) while employed by, or while serving as a non‑employee director of, or consultant or advisor to, us, then such option may be exercised at any time within one year after his termination of employment, termination of directorship, or termination of consulting or advisory arrangement or agreement due to the disability.  Notwithstanding the foregoing, in the event we are a party to an employment, consulting or advisory agreement with a holder of an option and such agreement provides for termination of employment or engagement based upon a disability or other incapacity, then, for such holder, a termination of employment or engagement for disability or other incapacity pursuant to the provisions thereof shall be considered to be a termination based upon permanent and total disability.

30

If an optionee is not an employee or non-employee director of, or a consultant or advisor to, our company as of a particular vesting date for an option due to death or termination of employment, termination of directorship or termination of consulting or advisory services due to permanent and total disability, then the optionee shall be deemed to have remained an employee or non-employee director of, or consultant or advisor to, us through the vesting date next following the date of death or date of termination of employment, termination of directorship or termination of consulting or advisory services due to permanent and total disability.  In the event of a change of control (as defined in the Plan), all outstanding options shall become fully vested.

Stock Appreciation Rights

The Committee may grant stock appreciation rights (an “SAR”) to such persons eligible under the Plan as selected from time to time.  SARs shall be granted at such times, in such amounts and under such other terms and conditions as the Committee shall determine.   An SAR entitles the grantee to exercise the SAR, in whole or in part, in exchange for payment of shares of our common stock, cash or a combination thereof, as determined by the Committee, equal in value to the excess of the fair market value of the shares of our common stock underlying the SAR, determined on the date of exercise, over the fair market value of our common stock underlying the SAR on the date of grant.

Corporate TransactionsNo SAR granted under the Plan shall be exercisable after the expiration of ten years from the date of its grant.

Stock Bonus Grants

The ESPP provides that,Committee may grant stock bonus awards to such persons eligible under the Plan as the Committee may select from time to time.  Stock bonus awards shall be granted at such times, in such amounts and under such other terms and conditions as the Committee shall determine.  Shares granted pursuant to a stock bonus shall vest as determined by the Committee, subject to certain restrictions as set forth in the Plan. Except as otherwise provided in the award agreement, a grantee shall forfeit the right to receive all shares not previously vested, if any, at such time as the grantee is no longer employed by, or serving as a director of, or rendering consulting or advisory services to, us or one of our parents or subsidiaries; however, if a stock bonus grantee is not an employee or non-employee director of, or a consultant or advisor to, our company as of a particular vesting date due to death or termination of employment, termination of directorship or termination of consulting or advisory services due to permanent and total disability, then the stock bonus grantee shall be deemed to have remained an employee or non-employee director of, or consultant or advisor to, us through the vesting date next following the date of death or date of termination of employment, termination or directorship or termination of consulting or advisory services due to permanent and total disability.  In the event of a reorganization, merger, or consolidationchange of the Company with one or more corporations or other entities in which the Company is not the surviving entity (or survives as a direct or indirect subsidiary of such other constituent corporation or its parent), or upon a sale of substantiallycontrol, all of the property oroutstanding stock of the Company to another corporation or other entity, a successor corporation or other entity may assume or substitute each outstanding option. If the successor corporation or other entity refuses to assume or substitute for the outstanding option, the offering period then in progress will be shortened, and a new purchase date will be set. The Company will notify each participant that the purchase date has been changed and that the participant’s option will be exercised automatically on the new purchase date unless prior to such date the participant has withdrawn from the offering period.bonus awards shall vest.

31

Amendment;Amendment and Termination

The Administrator, in its sole discretion, may amend, suspend,Plan (but not the options or stock bonuses previously granted thereunder) shall terminate on August 12, 2024, ten years from the ESPP at any time and for any reason. Ifdate that the ESPP is terminated,Plan was originally adopted by the Administrator, in its discretion, may electBoard.  Subject to terminatecertain limitations, the outstanding offering period either immediately or upon completion of the purchase of shares of our common stock on the next purchase date (whichPlan may be sooner than originally scheduled, if determinedamended or modified from time to time or terminated at an earlier date by the Administrator in its discretion),Board or may elect to permitby the offering period to expire in accordance with its terms. If the offering period is terminated prior to expiration, all amounts then credited to participants’ accounts that have not been used to purchase shares of our common stock will be returned to the participants as soon as administratively practicable.stockholders.

The Administrator may change the offering periods, designate separate offerings, limit the frequency and/or number of changes in the amount withheld during an offering period, permit contributions in excess of the amount designated by a participant in order to adjust for delays or mistakes in the Company’s processing of properly completed contribution elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of our common stock for each participant properly correspond with contribution amounts, and establish such other limitations or procedures as the Administrator determines in its sole discretion are advisable and are consistent with the ESPP. Such modifications will not require stockholder approval or the consent of any ESPP participants.

In addition, if the Administrator determines that the ongoing operation of the ESPP may result in unfavorable financial accounting consequences, the Administrator may, in its discretion, and, to the extent necessary or desirable, modify, amend or terminate the ESPP to reduce or eliminate such accounting consequence. Such modifications or amendments will not require stockholder approval or the consent of any ESPP participants.

In the event the stockholders approve the ESPP at the Annual Meeting, it will automatically terminate on August 10, 2031, unless terminated earlier by the Administrator.

Certain Federal Income Tax EffectsConsequences

The following discussion is intended only as a brief summary briefly describes U.S.of the federal income tax consequences ofrules relevant to stock options granted under the ESPP, butPlan.  These rules are highly technical and subject to change.  The following discussion is not a detailedlimited to the federal income tax rules relevant to us and to the individuals who are citizens or complete descriptionresidents of all U.S. federal tax laws or regulations that may apply, andthe United States.  The discussion does not address anystate, local state or other country laws. Therefore, no one should rely on this summary for individualforeign income tax compliance, planning or decisions. Participants in the ESPP should consult their own professional tax advisors concerning tax aspects of options granted under the ESPP. The discussion below concerning tax deductions that may become available to the Company under U.S. federal tax law is not intended to imply that the Company will necessarily obtain a tax benefit from those deductions.consequences.

The ESPPNonstatutory Stock Options

Under the Code and the Treasury Department Regulations, a nonstatutory stock option does not ordinarily have a readily ascertainable fair market value when it is intendedgranted. This rule will apply to our grant of nonstatutory stock options.  Consequently, the grant of a nonstatutory stock option to an optionee will result in neither income to him or her nor a deduction to us.  Instead, the optionee will recognize compensation income at the time he or she exercises the nonstatutory stock option in an amount equal to the excess, if any, of the then fair market value of the shares transferred to the optionee over the option price.  Subject to the applicable provisions of the Code and the Treasury Department Regulations regarding withholding of tax, a deduction will be allowable to us in the year of exercise in the same amount as is includable in the optionee’s income.

For purposes of determining the optionee’s gain or loss on the sale or other disposition of the shares transferred to him or her upon exercise of a nonstatutory stock option, the optionee’s basis in such shares will be the sum of the optionee’s option price plus the amount of compensation income recognized by him or her on exercise.  Such gain or loss will be capital gain or loss and will be long-term or short-term depending upon whether the optionee held the shares for more than one year or one year or less.  No part of any such gain will be an item of tax preference for purposes of the alternative minimum tax.

Incentive Stock Options

Options granted under the Plan which qualify as an “employeeincentive stock purchase plan” meeting the requirements ofoptions under Section 423422 of the Code. Under these provisions, a participantCode will notbe treated as follows:

Except to the extent that the alternative minimum tax rule described below applies, no tax consequences will result to the optionee or us from the grant of an incentive stock option to, or the exercise of an incentive stock option by, the optionee. Instead, the optionee will recognize taxable income untilgain or loss when he or she sells or otherwise disposes of the shares purchased undertransferred to him or her upon exercise of the ESPP.incentive stock option.  For purposes of determining such gain or loss, the optionee’s basis in such shares will be his or her option price. If a participant disposesthe date of sale or disposition of such shares is at least two years after the date of the grant of the incentive stock option, and at least one year after the transfer of the shares acquired underto the ESPP more than two years from the option grant date (i.e., the first dayoptionee upon exercise of the offering period) and more than oneincentive stock option, the optionee will realize long-term capital gain treatment upon their sale or disposition.

32

Generally, we will not be allowed a deduction with respect to an incentive stock option.  However, if an optionee fails to meet the foregoing holding period requirements (a so-called  disqualifying disposition), any gain recognized by the optionee upon the sale or disposition of the shares transferred to him or her upon exercise of an incentive stock option will be treated in the year from the date the stock is purchased, then the participant must treatof such sale or disposition as ordinary income, rather than capital gain, to the amount by whichextent of the lesserexcess, if any, of (i) the fair market value of the shares at the time of disposition,exercise (or, if less, in certain cases the amount realized on such sale or (ii)disposition) over their option price, and in that case we will be allowed a corresponding deduction.

For purposes of the alternative minimum tax, the amount, if any, by which the fair market value of the shares transferred to the optionee upon such exercise exceeds the option price will be included in determining the optionee’s alternative minimum taxable income.  In addition, for purposes of such tax, the basis of such shares will include such excess.

To the extent that the aggregate fair market value (determined at the time the option grant date,is granted) of the stock with respect to which incentive stock options are exercisable for the first time by the optionee during any calendar year exceeds $100,000, such options will not be incentive stock options.  In this regard, upon the purchase price. Any gainexercise of an option which is deemed, under the rule described in additionthe preceding sentence, to this amount willbe in part an incentive stock option and in part a nonstatutory stock option, under existing Internal Revenue Service guidelines, we may designate which shares issued upon exercise of such options are incentive stock options and which shares are nonstatutory stock options.  In the absence of such designation, a pro rata portion of each share issued is to be treated as issued pursuant to the exercise of an incentive stock option and the balance of each share treated as issued pursuant to the exercise of a capital gain. If a participant holds shares atnonstatutory stock option.

New Plan Benefits

The benefits that will be awarded or paid under the time of his or her death,Plan are not currently determinable. Awards granted under the holding period requirementsPlan are automatically deemed to have been satisfied and he or she will realize ordinary income inwithin the amount by which the lesser of (i) the fair market valuediscretion of the shares atCommittee, and the time of death,Committee has not determined future awards or (ii) the fair market value of the shares at the option grant date, exceeds the purchase price. The Company will not be allowed a deduction if the holding period requirements are satisfied.who might receive them.

If a participant disposes of shares prior to the expiration of two years from the date of grant or one year from the date the stock is purchased, then the participant is deemed to have a disqualifying disposition and must treat as ordinary income the excess of the fair market value of the shares on the purchase date over the purchase price. Any additional gain or loss will be treated as long-term or short-term capital gain or loss, depending on the participant’s holding period with respect to such shares. The Company will be allowed a deduction equal to the amount of ordinary income recognized by the participant in a disqualifying disposition.

New Plan Benefits

AsThe following table sets forth certain information regarding options and stock bonuses granted under the Plan (net of forfeitures), as of June 15, 2023, to (i) each person listed in the Summary Compensation Table under Executive Compensation, (ii) all current executive officers as a group, (iii) all current directors who are not executive officers as a group, (iv) each nominee for election as a director, (v) each associate of any such directors, executive officers or nominees, (vi) each other person who received 5% of the date of this proxy statement, no employee has beenoptions granted any options under the proposed ESPP. Accordingly, the benefits to be received pursuant to the ESPP by the Company’sand (vii) all employees, including current officers who are not executive officers, and employeesas a group:

33



Name and Position
Common Stock
Underlying
Options Granted
Weighted Average
Exercise Price
Per Share
Common
Stock Bonus
Grants
Barry B. Goldstein
Chief Executive Officer, President, Executive Chairman of the Board and Director
12,500$6.73453,691
Meryl S. Golden
Chief Operating Officer and Director
50,000$8.72163,511
Sarah (Minlei) Chen
Chief Actuary and Senior Vice President, Kingstone Insurance Company
-0-$-0-10,628
Floyd R. Tupper
Secretary and Director
-0-$-0-64,451
Timothy P. McFadden
Director (Lead Independent Director)
-0-$-0-59,246
William L. Yankus
Director
-0-$-0-63,951
Carla A. D’Andre
Director
-0-$-0-61,701
All current executive officers as a group62,500$8.32642,501
All current directors who are not executive officers as a group-0-$-0-249,349
All employees, including all current officers who are not executive officers, as a group64,701$7.94256,537

Equity Compensation Plan Information

The following table sets forth information as of December 31, 2022, with respect to compensation plans (including individual compensation arrangements) under which our shares of common stock are not determinable at this time.authorized for issuance, aggregated as follows:
     All compensation plans previously approved by security holders; and
     All compensation plans not previously approved by security holders.

34

 Number of securities to be issued upon exercise of outstanding options, warrants and rightsWeighted average exercise price of outstanding options, warrants and rightsNumber of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
 (a)(b)(c)
Equity compensation plans approved by security holders107,201$8.31979,976(1)
    
Equity compensation plans not approved by security holders---
    
Total107,201$8.31979,976(1)

(1)Includes 366,597 shares reserved for issuance pursuant to unvested restricted stock grants.

Vote Required

The approval of the Kingstone Companies, Inc. 2021 Employee Stock Purchaseamendment to the 2014 Plan requires the affirmative vote of stockholders who hold a majority of ourthe shares of common stock present in person or represented by proxy at the meeting and entitled to vote.

Recommendation

The Board of Directors recommends a vote FOR approval of the Kingstone Companies, Inc. 2021 Employee Stock Purchase Plan.amendment to the 2014 Plan increasing the number of shares authorized to be issued under the 2014 Plan from 1,400,000 to 1,900,000.


PROPOSAL 3: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee of our Board of Directors has selected Marcum LLP as our independent registered public accounting firm to examine our financial statements for the year ending December 31, 2023.

Although ratification by stockholders is not required by our organizational documents or other applicable law, our Board of Directors has determined that requesting ratification by stockholders of the appointment of Marcum as our independent registered public accounting firm for the fiscal year ending December 31, 2023, is a matter of good corporate practice. If stockholders do not ratify the selection, the Audit Committee may reconsider whether or not to retain Marcum, but may still determine to retain them. Even if the selection is ratified, the Audit Committee, in its discretion, may change the appointment at any time during the year if it determines that such a change would be in the best interests of us and our stockholders.

Marcum has served as our independent registered public accountants with respect to each fiscal year since the year ended December 31, 2013.

35

It is not expected that a representative of Marcum will attend the meeting.

The following is a summary of the fees billed to us by Marcum, our independent auditors, for professional services rendered for the fiscal years ended December 31, 2022 and 2021.

Fee Category 
Fiscal 2022 Fees
  
Fiscal 2021 Fees
 
Audit Fees(1) $275,010  $308,350 
Tax Fees(2) $-  $- 
Audit-Related Fees(3) $-  $- 
All Other Fees(4) $-  $- 
  $275,010  $308,350 

____________________

(1)Audit Fees consist of fees billed for services rendered for the audit of our consolidated financial statements and review of our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q, services rendered in response to due diligence requests, services rendered in connection with the filing of Form S-8, and services provided in connection with other statutory or regulatory filings.
(2)Marcum did not provide any tax services during the fiscal year.
(3)Marcum did not provide any “Audit-Related” services during the fiscal year.
(4)Marcum did not provide any other services during the fiscal year.

The Audit Committee is responsible for the appointment, compensation and oversight of the work of the independent auditors and approves in advance any services to be performed by the independent auditors, whether audit-related or not. The Audit Committee reviews each proposed engagement to determine whether the provision of services is compatible with maintaining the independence of the independent auditors. Substantially all of the fees shown above were pre-approved by the Audit Committee.

Vote Required

The ratification of the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023, requires the affirmative vote of stockholders who hold a majority of the shares of common stock present in person or represented by proxy at the meeting and entitled to vote.

Recommendation

The Board of Directors recommends a vote FOR the ratification of the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.


36

PROPOSAL 4: ADVISORY VOTE ON THE COMPENSATION OF
THE COMPANY’S NAMED EXECUTIVE OFFICERS

In accordance with the rules of the SEC, we are providing our stockholders with the opportunity to cast a non-binding advisory vote on the compensation of our named executive officers as disclosed pursuant to Item 402(m) through (q) of Regulation S-K, including the compensation tables and narrative discussion in this proxy statement.

The compensation structure established by our Compensation and Finance Committee is designed to attract and retain motivated executives who substantially contribute to our long-term success and the creation of stockholder value, to reward executives when we perform financially or operationally well, to align the financial interests of our executives with the interests of our stockholders, and to be competitive within our industry. We believe that our philosophy and practices have resulted in executive compensation decisions that are appropriate and that have benefited us over time.

We are requesting stockholder approval of the compensation of our executive officers as disclosed in this proxy statement. This proposal, commonly known as a “say-on-pay” proposal, gives our stockholders the opportunity to express their views on our executive officers’ compensation. Because the stockholder vote is advisory, it is not binding on us or our Board of Directors. However, our Board and the Compensation and Finance Committee, which is responsible for designing and administering our executive compensation program, value the opinions that our stockholders express in their votes. The Compensation and Finance Committee will review the results of the stockholder votes on this “say-on-pay” proposal and consider whether to recommend any changes or modifications to our executive compensation policies and practices as a result of such votes.

We are asking our stockholders to indicate their support for our named executive officer compensation through the following resolution:

RESOLVED, that the stockholders approve the compensation paid to our named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the compensation tables and narrative discussion in this proxy statement.”

Vote Required

The affirmative vote of the stockholders who hold a majority of our shares of common stock present in person or represented by proxy at the meeting and entitled to vote is required for approval of this proposal.

Recommendation

The Board of Directors recommends a vote FOR approval of the compensation of our named executive officers as disclosed in this proxy statement.

37

STOCKHOLDER PROPOSALS

Stockholder proposals intended to be presented at our next annual meeting of stockholders pursuant to the provisions of Rule 14a-8 of the Securities and Exchange Commission, promulgated under the Exchange Act, must be received at our offices in Kingston, New York by March 2, 20221, 2024, for inclusion in our proxy statement and form of proxy relating to such meeting.

The following requirements with respect to stockholder proposals and stockholder nominees to our Board of Directors are included in our By-Laws.

Stockholder Proposals

In order for a stockholder to make a proposal at an annual meeting of stockholders, under our By-Laws, timely notice must be received by us in advance of the meeting. To be timely, the proposal must be received by our Secretary at our principal executive offices (as provided below) on a date which is not less than 60 days nor more than 90 days prior to the date which is one year from the date of the mailing of the notice regarding the availability of proxy materials for the prior year’s annual meeting of stockholders. If during the prior year we did not hold an annual meeting, or if the date of the meeting for which a stockholder intends to submit a proposal has changed by more than 30 days from the date of the meeting in the prior year, then the notice must be received a reasonable time before we mail the notice regarding the availability of proxy materials for the current year. A stockholder’s notice must set forth as to each matter the stockholder proposes to bring before the annual meeting certain information regarding the proposal, including the following:

a brief description of the business desired to be brought before the meeting and the reasons for conducting such business at such meeting;

the name and address of the stockholder proposing such business;

the class and number of our shares which are beneficially owned by such stockholder; and

any material interest of such stockholder in such business. 

Stockholder Nominees

In order for a stockholder to nominate a candidate for director, under our By-Laws, timely notice of the nomination must be received by us in advance of the meeting. To be timely, the notice must be received at our principal executive offices (as provided below) not less than 60 days nor more than 90 days prior to the meeting; however, if less than 70 days’ notice of the date of the meeting is given to stockholders and public disclosure of the meeting date, pursuant to a press release, is either not made at all or is made less than 70 days prior to the meeting date, notice by a stockholder to be timely made must be so received no later than the close of business on the tenth day following the earlier of the following:
38


the day on which the notice of the date of the meeting was made available to stockholders, or

the day on which such public disclosure of the meeting date was made.

The stockholder sending the notice of nomination must describe various matters, including such information as:

the name, age, business and residential addresses, occupation or employment and shares held by the nominee;

any other information relating to such nominee required to be disclosed in a proxy statement; and

the name, address and number of shares held by the stockholder.

These requirements are separate from and in addition to the requirements a stockholder must meet to have a proposal included in our proxy statement.  In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must comply with the additional requirements of SEC Rule 14a-19(b).

Any notice given pursuant to the foregoing requirements must be sent to our Corporate Secretary at 15 Joys Lane, Kingston, New York 12401. The foregoing is only a summary of the provisions of our By-Laws that relate to stockholder proposals and stockholder nominations for director. Any stockholder desiring a copy of our By-Laws will be furnished one without charge upon receipt of a written request therefor.

OTHER BUSINESS

While the accompanying Notice of Annual Meeting of Stockholders provides for the transaction of such other business as may properly come before the meeting, we have no knowledge of any matters to be presented at the meeting other than those listed as Proposals 1, 2, 3, and 4 in the notice. However, the enclosed proxy gives discretionary authority in the event that any other matters should be presented.

FORM 10-K

This proxy statement is accompanied by a copy of our Annual Report on Form 10-K for the year ended December 31, 20202022 (excluding exhibits). We may charge a fee equal to our reasonable expenses in furnishing the exhibits.

Barry B. Goldstein
Chief Executive Officer

Kingston, New York
June 30, 202129, 2023
39



Appendix A

Employee Stock Purchase Plan


KINGSTONE COMPANIES, INC.
EMPLOYEE STOCK PURCHASE PLAN

1.Purpose. The purpose of the Plan is to provide  Eligible Employees of the Company and its Subsidiaries with an opportunity to purchase Common Stock through accumulated Contributions. The Company intends for the Plan to qualify as an "employee stock purchase plan" under Section 423 of the Code. Accordingly, the Plan will be construed so as to extend and limit Plan participation in a uniform and nondiscriminatory basis consistent with the requirements of Section 423 of the Code.
2.Definitions.
(a)"Administrator" means the Board or any Committee designated by the Board to administer the Plan pursuant to Section 14.
(b)"Applicable Laws" means the requirements relating to the administration of equity-based awards and the related issuance of shares of Common Stock under U.S. state corporate laws, U.S. federal and state securities laws, the Code, and any stock exchange or quotation system on which the Common Stock is listed or quoted.
(c)"Board" means the Board of Directors of the Company.
(d)"Code" means the U.S. Internal Revenue Code of 1986, as amended.
(e)"Committee" means the Compensation Committee of the Board.
(f)"Common Stock" means the common stock of the Company.
(g)"Company" means Kingstone Companies Inc., a Delaware corporation, or any successor thereto.
(h)"Compensation" shall be defined from time to time by the  Administrator in its sole discretion with respect to any Offering Period. Except as otherwise defined by the  Administrator from time to time in its sole discretion, "Compensation" means the pre-tax regular base wages paid to such Eligible Employee by the Company prior to reductions for pre-tax contributions made to plan or salary reduction contributions to a plan excludable from income under Sections 125 or  401(k) of the Code. Except as otherwise determined by the  Administrator, "Compensation" does not include: (1) any bonuses or commissions, (2) overtime pay, (3) any amounts contributed by the Company to any pension plan, (4) any automobile or relocation allowances (or reimbursement for any such expenses), (5) any amounts realized from the exercise of any stock options or other equity incentive awards, (6) any amounts paid by the Company for other fringe benefits, such as health and welfare, hospitalization and group life insurance benefits, or perquisites, or paid in lieu of such benefits, or (7) other similar forms of extraordinary compensation.
(i)"Contributions" means the payroll deductions used to fund the exercise of options granted pursuant to the Plan.
(j)"Designated Company" means any Subsidiary that has been designated by the Administrator from time to time in its sole discretion as eligible to participate in the Plan. As of the Effective Date,  the Subsidiaries listed on Exhibit A hereto are each a Designated  Company.
(k)"Designated Percent" means the percentage of Fair Market Value determined by the Administrator for purposes of determining the Purchase Price.
(l)"Effective Date" means the date that the Company's stockholders approve the Plan.
(m)"Eligible Employee" means any  employee providing services to the Company or a Designated Company, unless such employee is a member of a group or classification (as described in (i) through (iii) below) that is specifically excluded from participation as provided for below. The definition of Eligible Employee will not include an individual if he or she: (i) has not completed at least one (1) year of service since his or her last hire date; (ii) customarily works not more than twenty (20) hours per week; or (iii) customarily works not more than five (5) months per calendar year.
(n)"Employer" means the employer of the applicable Eligible Employee(s).
(o)"Exchange Act" means the U.S. Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder.
(p)"Fair Market Value" means, as of any date and unless the Administrator determines otherwise, the closing sales price for the Common Stock as quoted on the Nasdaq Stock Market on the date of determination (or the closing bid, if no sales were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable. Notwithstanding the foregoing, if the determination date for the Fair Market Value occurs on a weekend or holiday, the Fair Market Value will be the price as determined in accordance with the above on the immediately preceding business day, unless otherwise determined by the Administrator.
(q)"Maximum Share Amount" means the maximum number of  shares of Common Stock that a Participant may purchase on any given Purchase Date, as determined by the  Administrator in its sole discretion. Until specified otherwise by the  Administrator, the Maximum Share Amount shall be five thousand (5,000) shares of Common Stock, subject to adjustment pursuant to Section 19(a).
(r)"New Purchase Date" means a new Purchase Date if the Administrator shortens any Offering Period then in progress.
(s)"Offering" means an offer under the Plan of an option that may be exercised during an Offering Period.
(t)"Offering Date" means the first Trading Day of each Offering Period.
(u)"Offering Periods" means the period of time during which offers to purchase Common Stock are outstanding under the Plan. The  Administrator shall determine the length of each Offering Period, which need not be uniform; provided, that no Offering Period shall exceed twenty-seven (27) months in length. Offering Periods may be consecutive or overlapping. No voluntary payroll deductions shall be solicited until after the effective date of a registration statement on Form S-8 filed under the Securities Act covering the shares to be issued under the Plan.
(v)"Parent" means a "parent corporation," whether now or hereafter existing, as defined in Section 424(e) of the Code.
(w)"Participant" means an Eligible Employee that participates in the Plan.
(x)"Plan" means this Kingstone Companies, Inc. Employee Stock Purchase Plan.
(y)"Purchase Date" means the last Trading Day of the Offering Period.
(aa)"Purchase Price" means the Designated Percent of the Fair Market Value of a share of Common Stock on the Offering Date or on the Purchase Date, whichever is lower. Unless otherwise determined by the Administrator, the Designated Percent for purposes of the foregoing sentence is eighty-five percent (85%). The Administrator may change the Designated Percent for any Offering Period, but in no event shall the Designated Percent be less than eighty-five percent (85%).
(bb)"Securities Act" means the Securities Act of 1933, as amended from time to time.
(cc)"Subsidiary" means a "subsidiary corporation," whether now or hereafter existing, as defined in Section 424(f) of the Code.
(dd)"Trading  Day" means a day on which the Nasdaq Stock Market is open for trading.
(ee)"U.S. Treasury Regulations" means the Treasury regulations of the Code.
3.Eligibility.
(a)Offering  Periods. Any Eligible Employee on a given Offering Date will be eligible to participate in the Plan, subject to the requirements of Section 5.
(b)Limitations. Any provisions of the Plan to the contrary notwithstanding, no Eligible Employee will be granted an option under the Plan (i) to the extent that, immediately after the grant, such Eligible Employee (or any other person whose stock would be attributed to such Eligible Employee pursuant to Section 424(d) of the Code) would own capital stock of the Company or any Parent or Subsidiary of the Company and/or hold outstanding options to purchase such stock possessing five percent (5%) or more of the total combined voting power or value of all classes of the capital stock of the Company or of any Parent or Subsidiary of the Company, or (ii) to the extent that his or her rights to purchase stock under all employee stock purchase plans (as defined in Section 423 of the Code) of the Company or any Parent or Subsidiary of the Company accrues at a rate which exceeds twenty-five thousand dollars ($25,000) worth of stock (determined at the Fair Market Value of the stock at the time such option is granted) for each calendar year in which such option is outstanding at any time, as determined in accordance with Section 423 of the Code and the U.S. Treasury Regulations  thereunder.
4.Offering Periods. The Administrator will have the power to change the duration of Offering Periods (including the commencement dates thereof) without stockholder approval. Any such change shall be announced prior to the scheduled beginning of the first Offering Period to be affected thereafter.
5.Participation. An Eligible Employee may participate in the Plan by (i) submitting to the  Administrator (or its designee), on or before a date determined by the Administrator prior to an applicable Offering Date, a properly completed subscription agreement authorizing Contributions in the form provided by the Administrator for such purpose, or (ii) following an electronic or other enrollment procedure determined by the Administrator.
6.Contributions.
(a)At the time a Participant enrolls in the Plan pursuant to Section 5, he or she will elect to have Contributions made on each pay day during the Offering Period in an amount, expressed in one percent (1%) increments, that equals not less than one percent (1%) nor more than fifteen percent (15%)  of the Participant’s Compensation  during the Offering Period. A Participant's subscription agreement will remain in effect for successive Offering Periods unless terminated as provided for in Section 10.
(b)Payroll deductions for a Participant will commence on the first pay day following the Offering Date and will end on the last pay day prior to the Purchase Date of such Offering Period to which such authorization is applicable, unless sooner terminated by the Participant as provided for in Section 10.
(c)All Contributions made for a Participant will be credited to his or her account under the Plan and Contributions will be made in whole percentages only.
(d)A Participant may discontinue his or her participation in the Plan as provided in Section 10. A Participant may decrease (but not increase) the rate of his or her Contributions during an Offering Period by delivery of a subscription agreement to the Administrator or its designee; provided, however, that a Participant may make such a change only once per Offering Period. The change will become effective as soon as administratively practicable after receipt.
(e)Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code and Section 3(b) of the Plan, a Participant's Contributions may be decreased to zero percent (0%) at any time during an Offering Period. Subject to Section 423(b)(8) of the Code, Contributions will recommence at the rate originally elected by the Participant effective as of the beginning of the first Offering Period scheduled to end in the following calendar year, unless terminated by the Participant as provided in Section 10.
(f)At the time the option is exercised, in whole or in part, or at the time some or all of the Common Stock issued under the Plan is disposed of (or any other time that a taxable event related to the Plan occurs), the Participant must make adequate provision for the Company's or Employer's federal, state, local or any other tax liability, if any, which arise upon the exercise of the option or the disposition of the Common Stock (or any other time that a taxable event related to the Plan occurs). At any time, the Company or the Employer may, but will not be obligated to, withhold from the Participant's compensation the amount necessary for the Company or the Employer to meet applicable withholding obligations, including any withholding required to make available to the Company or the Employer any tax deductions or benefits attributable to the sale or early disposition of Common Stock by the Eligible Employee. In addition, the Company or the Employer may, but will not be obligated to, withhold from the proceeds of the sale of Common Stock or any other method of withholding the Company or the Employer deems appropriate to the extent permitted by U.S. Treasury Regulation Section 1.423-2(f).
7.Grant of Option. On the Offering Date of each Offering Period, each Eligible Employee participating in such Offering Period will be granted an option to purchase on each Purchase Date during such Offering Period (at the applicable Purchase Price) up to a number of shares of Common Stock determined by dividing such Eligible Employee's Contributions accumulated during such Offering Period prior to such Purchase Date and retained in the Eligible Employee's account as of the Purchase Date by the applicable Purchase Price; provided that in no event will an Eligible Employee be permitted to purchase during each Offering Period more than the Maximum Share Amount and provided further that such purchase will be subject to the limitations set forth in Sections 3(b) and 13. The Eligible Employee may accept the grant of such option by electing to participate in the Plan in accordance with the requirements of Section 5. The Administrator may, for future Offering Periods, increase or decrease, in its absolute discretion, the maximum number of shares of Common Stock that an Eligible Employee may purchase during each Offering Period. Exercise of the option will occur as provided in Section 8, unless the Participant has withdrawn pursuant to Section 10. The option will expire on the last day of the Offering Period.
8.Exercise of Option.
(a)Unless a Participant withdraws from the Plan as provided in Section 10, his or her option for the purchase of shares of Common Stock will be exercised automatically on the Purchase Date, and the maximum number of full shares subject to the option will be purchased for such Participant at the applicable Purchase Price with the accumulated Contributions from his or her account; provided that in no event will an Eligible Employee be permitted to purchase during each Offering Period more than the Maximum Share Amount and provided further that such purchase will be subject to the limitations set forth in Sections 3(b) and 13. No fractional shares of Common Stock will be purchased. Any Contributions accumulated in a Participant's account which are not sufficient to purchase a full share will be refunded to the Participant, without interest. During a Participant's lifetime, a Participant's option to purchase shares hereunder is exercisable only by him or her.
(b)In the event that the number of shares of Common Stock to be purchased by all Participants in any Offering Period exceeds the number of shares of Common Stock then available for issuance under the Plan, (i) the Company shall make a pro rata allocation of the remaining shares of Common Stock in as uniform a manner as shall be practicable and as the Committee shall, in its sole discretion, determine to be equitable and (ii) all funds not used to purchase shares of Common Stock on the Purchase Date shall be returned, without interest, to the Participants.
9.Delivery;  Dispositions.
(a)As soon as reasonably practicable after each Purchase Date on which a purchase of shares of Common Stock occurs, the Company will arrange the delivery to each Participant of the shares purchased upon exercise of his or her option in a form determined by the Administrator (in its sole discretion) and pursuant to rules established by the Administrator. The Company may permit or require that shares be deposited directly with a broker designated by the Company or to a designated agent of the Company, and the Company may utilize electronic or automated methods of share transfer. The Company may require that shares be retained with such broker or agent for a designated period of time and/or may establish other procedures to permit tracking of disqualifying dispositions of such shares. No Participant will have any voting, dividend, or other stockholder rights with respect to shares of Common Stock subject to any option granted under the Plan until such shares have been purchased and delivered to the Participant as provided in this Section 9.
(b)At the time a Participant sells any shares of Common Stock acquired under the Plan, he or she shall provide written notice to the Administrator as to the number of shares sold and the sale price thereof so that the Company may determine whether a qualifying or disqualifying disposition has occurred for purposes of the Code and the tax effects thereof.
10.Withdrawal.
(a)A Participant may withdraw all but not less than all the Contributions credited to his or her account and not yet used to exercise his or her option under the Plan at any time by (i) submitting to the Company's  Administrator (or its designee) a written notice of withdrawal in the form determined by the Administrator for such purpose (which may be similar to the form attached hereto as Exhibit B), or (ii) following an electronic or other withdrawal procedure determined by the Administrator. All of the Participant's Contributions credited to his or her account will be paid to such Participant, without interest, promptly after receipt of notice of withdrawal and such Participant's option for the Offering Period will be automatically terminated, and no further Contributions for the purchase of shares will be made for such Offering Period. If a Participant withdraws from an Offering Period, Contributions will not resume at the beginning of the succeeding Offering Period, unless the Participant re-enrolls in the Plan in accordance with the provisions of Section 5.
(b)A Participant's withdrawal from an Offering Period will not have any effect upon his or her eligibility to participate in any similar plan that may hereafter be adopted by the Company or in succeeding Offering Periods that commence after the termination of the Offering Period from which the Participant withdraws.
11.Termination of Employment. Upon a Participant's ceasing to be an Eligible Employee, for any reason, he or she will be deemed to have elected to withdraw from the Plan and the Contributions credited to such Participant's account during the Offering Period but not yet used to purchase shares of Common Stock under the Plan will be returned, without interest, to such Participant or, in the case of his or her death, to the person or persons entitled thereto under Section 15, and such Participant's option will be automatically terminated. Unless determined otherwise by the Administrator in a manner that is permitted by, and compliant with, Section 423 of the Code, a Participant whose employment transfers between entities through a termination with an immediate rehire (with no break in service) by the Company or a Designated Company shall not be treated as terminated under the Plan.
12.Interest. No interest will accrue on the Contributions of a Participant in the Plan.
13.Stock.
(a)Subject to adjustment as provided in Section 19, the maximum number of shares of Common Stock that will be made available for sale under the Plan will be seven hundred fifty thousand (750,000) shares of Common Stock.
(b)If any option granted under the Plan shall for any reason terminate without having been exercised, the shares of Common Stock not purchased under such option shall again become available for issuance under the Plan.
(c)The shares of Common Stock purchasable under the Plan shall be shares of authorized, but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market.
14.Administration. Unless otherwise designated by the Board, the Committee shall serve as the Administrator. The Administrator will have full and exclusive discretionary authority to construe, interpret, and apply the terms of the Plan to designate separate Offerings under the Plan, to designate a Subsidiary  as  a Designated Company, to determine eligibility, to adjudicate all disputed claims filed under the Plan and to establish such procedures that it deems necessary for the administration of the Plan. Without limiting the generality of the foregoing, the Administrator is specifically authorized to adopt rules and procedures regarding eligibility to participate, the definition of Compensation, handling of Contributions, making of Contributions to the Plan, establishment of bank or trust accounts to hold Contributions, obligations to pay payroll tax, determination of beneficiary designation requirements, withholding procedures and handling of stock certificates that vary with applicable local requirements. Every finding, decision, and determination made by the Administrator will, to the full extent permitted by law, be final and binding upon all parties. With respect to employees of the Company or any entity that, directly or indirectly, is controlled by the Company, and any entity in which the Company has a significant equity interest, in either case as determined by the Committee, who reside or work outside the United States of America, the Committee may, in its sole discretion, amend the terms of the Plan with respect to such employees in order to conform such terms with the provisions of local law, and the Committee may, where appropriate, establish one or more plans or sub-plans to reflect such amended or varied provisions.
15.Designation of Beneficiary. A Participant may file, on forms supplied by the Administrator, a written designation of beneficiary who is to receive any shares of Common Stock and cash, if any, from the Participant's Account under the Plan in the event of such Participant's death. In addition, a Participant may file a written designation of beneficiary who is to receive any cash withheld through payroll deductions and credited to the Participant's notional account in the event of the Participant's death prior to the Purchase Date of an Offering Period.
16.Transferability. Neither Contributions credited to a Participant's account nor any rights with regard to the exercise of an option or to receive shares of Common Stock under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution, or as provided for in Section 15) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition will be without effect, except that the Company may treat such act as an election to withdraw funds from an Offering Period in accordance with Section 10.
17.Use of Funds. The Company may use all Contributions received or held by it under the Plan for any corporate purpose, and the Company will not be obligated to segregate such Contributions. Until shares of Common Stock are issued, Participants will only have the rights of an unsecured creditor with respect to the Plan.
18.Reports. Individual accounts will be maintained for each Participant in the Plan. Statements of account will be given to participating Eligible Employees at least annually, which statements will set forth the amounts of Contributions, the Purchase Price, the number of shares of Common Stock purchased and the remaining cash balance, if any.
19.Adjustments;  Dissolution or Liquidation;  Corporate Transactions.
(a)Adjustments. In the event of a stock dividend, stock split or combination of shares, recapitalization or other change in the Company's capitalization, or other distribution with respect to holders of the Company's Common Stock other than normal cash dividends, an automatic adjustment shall be made in the number and kind of shares as to which outstanding options then unexercised shall be exercisable, in the available shares set forth in Section 13, and in the Purchase Period limit under Section 7, so that the proportionate interest of the Participants shall be maintained as before the occurrence of such event; provided, however, that in no event shall any adjustment be made that would cause any option to fail to qualify as an option pursuant to an employee stock purchase plan within the meaning of Section 423 of the Code.
(b)Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, any Offering Period then in progress will be shortened by setting a New Purchase Date, and will terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Administrator. The New Purchase Date will be before the date of the Company's proposed dissolution or liquidation. The Administrator will notify each Participant in writing or electronically, prior to the New Purchase Date, that the Purchase Date for the Participant's option has been changed to the New Purchase Date and that the Participant's option will be exercised automatically on the New Purchase Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided for in Section 10.
(c)Certain Corporate Transactions. In the event of a reorganization, merger, or consolidation of the Company with one or more corporations or other entities in which the Company is not the surviving entity (or survives as a direct or indirect subsidiary of such other constituent corporation or other entity or its parent), or upon a sale of substantially all of the property or stock of the Company to another corporation or other entity, each outstanding option will be assumed or an equivalent option substituted by the successor corporation or other entity or a Parent or Subsidiary of the successor corporation or other entity. In the event that the successor corporation or other entity refuses to assume or substitute for the option, the Offering Period with respect to which such option relates will be shortened by setting a New Purchase Date on which such Offering Period shall end. The New Purchase Date will occur before the date of the Company's proposed transaction. The Administrator will notify each Participant in writing or electronically prior to the New Purchase Date, that the Purchase Date for the Participant's option has been changed to the New Purchase Date and that the Participant's option will be exercised automatically on the New Purchase Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided for in Section 10.
20.Amendment or Termination.
(a)The Administrator, in its sole discretion, may amend, suspend, or terminate the Plan, or any part thereof, at any time and for any reason. If the Plan is terminated, the Administrator, in its discretion, may elect to terminate the outstanding Offering Period either immediately or upon completion of the purchase of shares of Common Stock on the next Purchase Date (which may be sooner than originally scheduled, if determined by the Administrator in its discretion), or may elect to permit the Offering Period to expire in accordance with its terms (and subject to any adjustment pursuant to Section 19). If the Offering Period is terminated prior to expiration, all amounts then credited to Participants' accounts that have not been used to purchase shares of Common Stock will be returned to the Participants (without interest thereon) as soon as administratively practicable.
(b)Without Participant consent and without limiting Section 20(a), the Administrator will be entitled to change the Offering Periods, designate separate Offerings, limit the frequency and/or number of changes in the amount withheld during an Offering Period, permit Contributions in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the Company's processing of properly completed Contribution elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with Contribution amounts, and establish such other limitations or procedures as the Administrator determines in its sole discretion advisable that are consistent with the Plan.
(c)Without limiting the foregoing, in the event the Administrator determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Administrator may, in its discretion and, to the extent necessary or desirable, modify, amend, or terminate the Plan to reduce or eliminate such accounting consequence including, but not limited to:
(i)amending the Plan to conform with the safe harbor definition under the Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto), including with respect to an Offering Period underway at the time;
(ii)altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase Price;
(iii)shortening any Offering Period by setting a New Purchase Date, including an Offering Period underway at the time of the Administrator action;
(iv)reducing the maximum percentage of Compensation a Participant may elect to set aside as Contributions; and
(v)reducing the maximum number of Shares a Participant may purchase during any Offering Period.
Such modifications or amendments will not require stockholder approval or the consent of any Plan Participants.
21.Notices. All notices or other communications by a Participant to the Company under or in connection with the Plan will be deemed to have been duly given when received in the form and manner specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.
22.Conditions Upon Issuance of Shares. Shares of Common Stock will not be issued with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto will comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act, the Exchange Act, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and will be further subject to the approval of counsel for the Company with respect to such compliance. As a condition to the exercise of an option, the Company may require the person exercising such option to represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned applicable provisions of law.
23.Term of Plan. The Plan will be effective as of the Effective Date and will continue in effect through the tenth (10th) anniversary thereof, unless sooner terminated under Section 20.
24.Stockholder Approval. The Plan will be subject to approval by the stockholders of the Company within twelve (12) months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws.
25.Governing  Law. The Plan shall be governed by, and construed in accordance with, the laws of the State of New York (except its choice-of-law provisions).
26.No Right to Employment. Participation in the Plan by a Participant shall not be construed as giving a Participant the right to be retained as an employee of the Company or a Subsidiary. Furthermore, the Company or a Subsidiary may dismiss a Participant from employment at any time, free from any liability or any claim under the Plan.
27.Severability. If any provision of the Plan is or becomes or is deemed to be invalid, illegal, or unenforceable for any reason in any jurisdiction or as to any Participant, such invalidity, illegality or unenforceability shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as to such jurisdiction or Participant as if the invalid, illegal or unenforceable provision had not been included.
28.Compliance with Applicable Laws. The terms of this Plan are intended to comply with all Applicable Laws and will be construed accordingly.

EXHIBIT A
KINGSTONE COMPANIES, INC.
EMPLOYEE STOCK PURCHASE PLAN
DESIGNATED COMPANIES


1.Kingstone Insurance Company
2.Cosi Agency, Inc.



EXHIBIT B
KINGSTONE COMPANIES, INC.
EMPLOYEE STOCK PURCHASE PLAN
SUBSCRIPTION AGREEMENT

____ Original Application                                                      Offering Date:_________
____ Reduction in Payroll Deduction Rate

Capitalized terms used but not otherwise defined herein shall have the meaning given to
such terms in the Kingstone Companies, Inc. Employee Stock Purchase Plan.

1.I,_____________________________ , hereby elect to participate in the Kingstone Companies, Inc. Employee Stock Purchase Plan (the "Plan") and subscribe to purchase shares of Common Stock in accordance with this Employee Stock Purchase Plan Subscription Agreement (the "Subscription Agreement") and the Plan.
2.I hereby authorize payroll deductions from each paycheck in the amount of___ % of my Compensation on each payday (from 0% to 15%) during the Offering Period in accordance with the Plan. (Please note that no fractional percentages are permitted.)
3.I understand that said payroll deductions will be accumulated for the purchase of shares of Common Stock at the applicable Purchase Price determined in accordance with the Plan. I understand that if I do not withdraw from an Offering Period, any accumulated payroll deductions will be used to automatically exercise my option and purchase Common Stock under the Plan.
4.I have received a copy of the complete Plan and its accompanying prospectus. I understand that my participation in the Plan is in all respects subject to the terms of the Plan. The Company reserves the right to modify the Plan and to impose other requirements on my participation in the Plan, on the option and on any shares of Common Stock purchased under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons. I agree to be bound by such modifications regardless of whether notice is given to me of such event, subject, in any case, to my right to withdraw from participation in the Plan. I further agree to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
5.I hereby explicitly and unambiguously consent to the collection, use, and transfer, in electronic or other form, of my personal data as described in the Agreement and any other grant materials by and among, as applicable, the Company and any Designated Company for the exclusive purpose of implementing, administering, and managing my participation in the Plan.
6.I understand that the Company and each Designated Company may hold certain personal information about me, including, but not limited to, my name, home address, email address, telephone number, date of birth, social security number, passport number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all purchase rights or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested, or outstanding in my favor (“Data”), for the exclusive purpose of implementing, administering, and managing the Plan.
7.I understand that Data will be transferred to the Company’s designated third-party broker or other third party (“Online Administrator”) and its affiliated companies or such other stock plan service provider as may be designated by the Company from time to time, which is assisting the Company with the implementation, administration, and management of the Plan. I understand that the recipients of Data may be located in the United States or elsewhere, and that the recipients’ country may have different data privacy laws and protections than my country. I authorize the Company, Online Administrator, or such other stock plan service provider as may be designated by the Company from time to time, and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering, and managing the Plan to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering, and managing my participation in the Plan. I understand that Data will be held only as long as is necessary to implement, administer, and manage my participation in the Plan. Further, I understand that I am providing the consents herein on a purely voluntary basis. If I do not consent, or if I later seek to revoke my consent, my employment status or service with the Employer will not be affected; the only consequence of refusing or withdrawing my consent is that the Company would not be able to grant options to me or administer or maintain such awards. Therefore, I understand that refusing or withdrawing my consent may affect my ability to participate in the Plan. For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.
8.Upon request of the Company or the Employer, I agree to provide an executed data privacy consent form (or other agreement or consent) that the Company or the Employer may deem necessary to obtain from me for the purpose of administering my participation in the Plan in compliance with the data privacy laws in my country either now or in the future. I understand and agree that I will not be able to participate in the Plan if I fail to provide any such consent or agreement requested by the Company and/or the Employer.
9.I hereby agree to be bound by the terms of the Plan and this Subscription Agreement. The effectiveness of this Subscription Agreement is dependent upon my eligibility to participate in the Plan.
Employee's Tax ID Number:

I ACKNOWLEDGE AND UNDERSTAND THAT THIS SUBSCRIPTION AGREEMENT INCLUDING ITS APPENDICES AND MY PARTICIPATION IN THE PLAN WILL REMAIN IN EFFECT THROUGHOUT SUCCESSIVE OFFERING PERIODS UNLESS AFFIRMATIVELY TERMINATED BY ME.


Dated:



Signature of Employee